<html class="gs_el_sm gs_pfcs"><head><title>‪Philippe Clezardin‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.com/citations?user=ZL2owqcAAAAJ&amp;hl=en"><meta name="description" content="‪Professor in Bone Oncology‬ - ‪‪Cited by 13,127‬‬ - ‪bone‬ - ‪metastasis‬ - ‪breast cancer‬"><meta property="og:description" content="‪Professor in Bone Oncology‬ - ‪‪Cited by 13,127‬‬ - ‪bone‬ - ‪metastasis‬ - ‪breast cancer‬"><meta property="og:title" content="Philippe Clezardin"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=ZL2owqcAAAAJ&amp;citpid=1"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"fQpSYbP_D5KTy9YPlZ23uAE"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=ZL2owqcAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=ZL2owqcAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=ZL2owqcAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=ZL2owqcAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYVNb_YPCOkPOUjqiq7Rdzcmfc_f1TaCp"><input type="hidden" name="user" value="ZL2owqcAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">13127</td><td class="gsc_rsb_std">3998</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">63</td><td class="gsc_rsb_std">38</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">134</td><td class="gsc_rsb_std">97</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:1218px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:1176px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">840</div><div class="gsc_g_xtl" style="top:73px;">420</div><div class="gsc_g_xtl" style="top:113px;">210</div><div class="gsc_g_xtl" style="top:33px;">630</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:1123px">1986</span><span class="gsc_g_t" style="right:1091px">1987</span><span class="gsc_g_t" style="right:1059px">1988</span><span class="gsc_g_t" style="right:1027px">1989</span><span class="gsc_g_t" style="right:995px">1990</span><span class="gsc_g_t" style="right:963px">1991</span><span class="gsc_g_t" style="right:931px">1992</span><span class="gsc_g_t" style="right:899px">1993</span><span class="gsc_g_t" style="right:867px">1994</span><span class="gsc_g_t" style="right:835px">1995</span><span class="gsc_g_t" style="right:803px">1996</span><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:1128px;top:153px;height:7px;z-index:36"><span class="gsc_g_al">40</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1096px;top:147px;height:13px;z-index:35"><span class="gsc_g_al">70</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1064px;top:154px;height:6px;z-index:34"><span class="gsc_g_al">36</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1032px;top:148px;height:12px;z-index:33"><span class="gsc_g_al">65</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1000px;top:152px;height:8px;z-index:32"><span class="gsc_g_al">44</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:968px;top:145px;height:15px;z-index:31"><span class="gsc_g_al">80</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:936px;top:145px;height:15px;z-index:30"><span class="gsc_g_al">81</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:904px;top:141px;height:19px;z-index:29"><span class="gsc_g_al">103</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:872px;top:150px;height:10px;z-index:28"><span class="gsc_g_al">53</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:840px;top:146px;height:14px;z-index:27"><span class="gsc_g_al">76</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:808px;top:150px;height:10px;z-index:26"><span class="gsc_g_al">54</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:149px;height:11px;z-index:25"><span class="gsc_g_al">62</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:148px;height:12px;z-index:24"><span class="gsc_g_al">64</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:140px;height:20px;z-index:23"><span class="gsc_g_al">105</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:141px;height:19px;z-index:22"><span class="gsc_g_al">100</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:132px;height:28px;z-index:21"><span class="gsc_g_al">152</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:121px;height:39px;z-index:20"><span class="gsc_g_al">205</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:107px;height:53px;z-index:19"><span class="gsc_g_al">281</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:99px;height:61px;z-index:18"><span class="gsc_g_al">321</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:77px;height:83px;z-index:17"><span class="gsc_g_al">436</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:82px;height:78px;z-index:16"><span class="gsc_g_al">413</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:78px;height:82px;z-index:15"><span class="gsc_g_al">435</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:54px;height:106px;z-index:14"><span class="gsc_g_al">558</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:45px;height:115px;z-index:13"><span class="gsc_g_al">604</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:37px;height:123px;z-index:12"><span class="gsc_g_al">650</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:29px;height:131px;z-index:11"><span class="gsc_g_al">690</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:14px;height:146px;z-index:10"><span class="gsc_g_al">769</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:9px;height:151px;z-index:9"><span class="gsc_g_al">793</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:3px;height:157px;z-index:8"><span class="gsc_g_al">829</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:10px;height:150px;z-index:7"><span class="gsc_g_al">790</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:19px;height:141px;z-index:6"><span class="gsc_g_al">741</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:33px;height:127px;z-index:5"><span class="gsc_g_al">667</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:33px;height:127px;z-index:4"><span class="gsc_g_al">670</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:34px;height:126px;z-index:3"><span class="gsc_g_al">665</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:30px;height:130px;z-index:2"><span class="gsc_g_al">684</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:53px;height:107px;z-index:1"><span class="gsc_g_al">563</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=ZL2owqcAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dZL2owqcAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>34 articles</span></div><div class="gsc_rsb_m_na"><div>5 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:13%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:85px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:53pt;height:80pt;}}</style><img alt="Philippe Clezardin" sizes="print 53px,85px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=ZL2owqcAAAAJ&amp;citpid=1" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=ZL2owqcAAAAJ&amp;citpid=1 85w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=ZL2owqcAAAAJ&amp;citpid=1 170w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Philippe Clezardin</div><div class="gsc_prf_il">Professor in Bone Oncology</div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at sheffield.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:bone" class="gsc_prf_inta gs_ibl">bone</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:metastasis" class="gsc_prf_inta gs_ibl">metastasis</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:breast_cancer" class="gsc_prf_inta gs_ibl">breast cancer</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=ZL2owqcAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYVNb_YPCOkPOUjqiq7Rdzcmfc_f1TaCp"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=ZL2owqcAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=ZL2owqcAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=ZL2owqcAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=ZL2owqcAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=ZL2owqcAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:RGFaLdJalmkC" class="gsc_a_at">Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases</a><div class="gs_gray">S Boissier, M Ferreras, O Peyruchaud, S Magnetto, FH Ebetino, ...</div><div class="gs_gray">Cancer research 60 (11), 2949-2954<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5273160601804261885" class="gsc_a_ac gs_ibl">785</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats</a><div class="gs_gray">P Fournier, S Boissier, S Filleur, J Guglielmi, F Cabon, M Colombel, ...</div><div class="gs_gray">Cancer research 62 (22), 6538-6544<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6676414965701654266" class="gsc_a_ac gs_ibl">771</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:738O_yMBCRsC" class="gsc_a_at">Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer</a><div class="gs_gray">A Boucharaba, CM Serre, S Grès, JS Saulnier-Blache, JC Bordet, ...</div><div class="gs_gray">The Journal of clinical investigation 114 (12), 1714-1725<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7738566891822834054" class="gsc_a_ac gs_ibl">460</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices</a><div class="gs_gray">S Boissier, S Magnetto, L Frappart, B Cuzin, FH Ebetino, PD Delmas, ...</div><div class="gs_gray">Cancer research 57 (18), 3890-3894<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6042153472029427463" class="gsc_a_ac gs_ibl">441</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth</a><div class="gs_gray">S Filleur, A Courtin, S Ait-Si-Ali, J Guglielmi, C Merle, A Harel-Bellan, ...</div><div class="gs_gray">Cancer research 63 (14), 3919-3922<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1939423577010633260" class="gsc_a_ac gs_ibl">361</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Integrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to bone</a><div class="gs_gray">I Pecheur, O Peyruchaud, CM Serre, J Guglielmi, C Voland, F Bourre, ...</div><div class="gs_gray">The FASEB Journal 16 (10), 1266-1268<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8738930175039211104" class="gsc_a_ac gs_ibl">275</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity</a><div class="gs_gray">P Clézardin, FH Ebetino, PGJ Fournier</div><div class="gs_gray">Cancer research 65 (12), 4971-4974<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3373254505586459280" class="gsc_a_ac gs_ibl">271</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:NJ774b8OgUMC" class="gsc_a_at">Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis</a><div class="gs_gray">F Daubiné, C Le Gall, J Gasser, J Green, P Clézardin</div><div class="gs_gray">Journal of the National Cancer Institute 99 (4), 322-330<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11396282085986737833" class="gsc_a_ac gs_ibl">260</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases</a><div class="gs_gray">A Boucharaba, CM Serre, J Guglielmi, JC Bordet, P Clézardin, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 103 (25), 9643-9648<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10221177382622162602" class="gsc_a_ac gs_ibl">241</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Tumor αvβ3 integrin is a therapeutic target for breast cancer bone metastases</a><div class="gs_gray">Y Zhao, R Bachelier, I Treilleux, P Pujuguet, O Peyruchaud, R Baron, ...</div><div class="gs_gray">Cancer research 67 (12), 5821-5830<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12592783231696074188" class="gsc_a_ac gs_ibl">228</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer</a><div class="gs_gray">JT Buijs, NV Henriquez, PGM Van Overveld, G Van der Horst, I Que, ...</div><div class="gs_gray">Cancer research 67 (18), 8742-8751<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11330242817995864621" class="gsc_a_ac gs_ibl">227</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">Bisphosphonates in cancer therapy</a><div class="gs_gray">V Stresing, F Daubiné, I Benzaid, H Mönkkönen, P Clézardin</div><div class="gs_gray">Cancer letters 257 (1), 16-35<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10739561976786619835" class="gsc_a_ac gs_ibl">224</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:0EnyYjriUFMC" class="gsc_a_at">Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment&nbsp;…</a><div class="gs_gray">O Peyruchaud, B Winding, I Pécheur, CM Serre, P Delmas, P Clézardin</div><div class="gs_gray">Journal of Bone and Mineral Research 16 (11), 2027-2034<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1696268117616693366" class="gsc_a_ac gs_ibl">205</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast</a><div class="gs_gray">P Clezardin, L Frappart, M Clerget, C Pechoux, PD Delmas</div><div class="gs_gray">Cancer research 53 (6), 1421-1430<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=365867701101186323" class="gsc_a_ac gs_ibl">204</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:u_35RYKgDlwC" class="gsc_a_at">A cathepsin K inhibitor reduces breast cancer–induced osteolysis and skeletal tumor burden</a><div class="gs_gray">C Le Gall, A Bellahcene, E Bonnelye, JA Gasser, V Castronovo, J Green, ...</div><div class="gs_gray">Cancer research 67 (20), 9894-9902<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6159532613778313719" class="gsc_a_ac gs_ibl">201</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:YohjEiUPhakC" class="gsc_a_at">Increased Dickkopf-1 expression in breast cancer bone metastases</a><div class="gs_gray">N Voorzanger-Rousselot, D Goehrig, F Journe, V Doriath, JJ Body, ...</div><div class="gs_gray">British journal of cancer 97 (7), 964-970<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16770682401560603846" class="gsc_a_ac gs_ibl">184</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients</a><div class="gs_gray">D Santini, G Schiavon, B Vincenzi, L Gaeta, F Pantano, A Russo, ...</div><div class="gs_gray">PloS one 6 (4), e19234<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11646205325859597733" class="gsc_a_ac gs_ibl">180</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Effects of bone-targeted agents on cancer progression and mortality</a><div class="gs_gray">R Coleman, M Gnant, G Morgan, P Clezardin</div><div class="gs_gray">Journal of the National Cancer Institute 104 (14), 1059-1067<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3784554337525378076" class="gsc_a_ac gs_ibl">179</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:5awf1xo2G04C" class="gsc_a_at">Recent insights into the role of integrins in cancer metastasis</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">Cellular and Molecular Life Sciences CMLS 54 (6), 541-548<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10494858842001196233" class="gsc_a_ac gs_ibl">174</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;citation_for_view=ZL2owqcAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Rapid purification and partial characterization of human platelet glycoprotein IIIb: interaction with thrombospondin and its role in platelet aggregation</a><div class="gs_gray">JL McGregor, B Catimel, S Parmentier, P Clezardin, M Dechavanne, ...</div><div class="gs_gray">Journal of Biological Chemistry 264 (1), 501-506<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9820710612960008807" class="gsc_a_ac gs_ibl">165</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:PELIpwtuRlgC" class="gsc_a_at">Direct and indirect anticancer activity of bisphosphonates: a brief review of published literature</a><div class="gs_gray">M Gnant, P Clézardin</div><div class="gs_gray">Cancer treatment reviews 38 (5), 407-415<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10076798262523365324" class="gsc_a_ac gs_ibl">164</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Bone 48 (1), 71-79<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6336651293736293999" class="gsc_a_ac gs_ibl">162</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Bone metastasis: pathogenesis and therapeutic implications</a><div class="gs_gray">P Clezardin, A Teti</div><div class="gs_gray">Clinical &amp; experimental metastasis 24 (8), 599-608<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13027703576198300367" class="gsc_a_ac gs_ibl">159</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vγ9Vδ2 T-cell chemotaxis and cytotoxicity in vivo</a><div class="gs_gray">I Benzaïd, H Mönkkönen, V Stresing, E Bonnelye, J Green, J Mönkkönen, ...</div><div class="gs_gray">Cancer research 71 (13), 4562-4572<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17196852571464945095" class="gsc_a_ac gs_ibl">147</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:hMsQuOkrut0C" class="gsc_a_at">Thrombospondin-1 and-2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and&nbsp;…</a><div class="gs_gray">N Bertin, P Clezardin, R Kubiak, L Frappart</div><div class="gs_gray">Cancer research 57 (3), 396-399<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13810601921413386501" class="gsc_a_ac gs_ibl">145</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:UHK10RUVsp4C" class="gsc_a_at">The HIF-1–inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth</a><div class="gs_gray">F Pez, F Dayan, J Durivault, B Kaniewski, G Aimond, GS Le Provost, ...</div><div class="gs_gray">Cancer research 71 (5), 1647-1657<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11302431476314836813" class="gsc_a_ac gs_ibl">143</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:dhFuZR0502QC" class="gsc_a_at">Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel</a><div class="gs_gray">P Hadji, RE Coleman, C Wilson, TJ Powles, P Clézardin, M Aapro, ...</div><div class="gs_gray">Annals of Oncology 27 (3), 379-390<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5605155776630200448" class="gsc_a_ac gs_ibl">140</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis</a><div class="gs_gray">JR Green, P Clézardin</div><div class="gs_gray">American journal of clinical oncology 25 (6), S3-S9<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16520808659933690688" class="gsc_a_ac gs_ibl">139</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:ufrVoPGSRksC" class="gsc_a_at">Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts</a><div class="gs_gray">M David, E Wannecq, F Descotes, S Jansen, B Deux, J Ribeiro, CM Serre, ...</div><div class="gs_gray">PloS one 5 (3), e9741<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1226476745623256789" class="gsc_a_ac gs_ibl">134</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain</a><div class="gs_gray">B Merle, L Durussel, PD Delmas, P Clézardin</div><div class="gs_gray">Journal of cellular biochemistry 75 (3), 538-546<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5166307869630856292" class="gsc_a_ac gs_ibl">131</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Metastasis and bone loss: advancing treatment and prevention</a><div class="gs_gray">RE Coleman, A Lipton, GD Roodman, TA Guise, BF Boyce, AM Brufsky, ...</div><div class="gs_gray">Cancer treatment reviews 36 (8), 615-620<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16211862204007151698" class="gsc_a_ac gs_ibl">126</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Additive antitumor activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to bone</a><div class="gs_gray">S Magnetto, S Boissier, PD Delmas, P Clezardin</div><div class="gs_gray">International journal of cancer 83 (2), 263-269<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16900094130196455142" class="gsc_a_ac gs_ibl">126</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:HeT0ZceujKMC" class="gsc_a_at">A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, β-thromboglobulin and platelet factor 4 in healthy volunteers</a><div class="gs_gray">J Dawes, KJ Clemetson, GO Gogstad, J McGregor, P Clezardin, ...</div><div class="gs_gray">Thrombosis research 29 (6), 569-581<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11243894363472956165" class="gsc_a_ac gs_ibl">118</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Interaction of platelet-derived autotaxin with tumor integrin α<sub>V</sub>β<sub>3</sub> controls metastasis of breast cancer cells to bone</a><div class="gs_gray">R Leblanc, SC Lee, M David, JC Bordet, DD Norman, R Patil, D Miller, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (20), 3141-3150<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2037889475761128050" class="gsc_a_ac gs_ibl">117</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:8k81kl-MbHgC" class="gsc_a_at">In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects</a><div class="gs_gray">S Filleur, OV Volpert, A Degeorges, C Voland, F Reiher, P Clézardin, ...</div><div class="gs_gray">Genes &amp; development 15 (11), 1373-1382<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1825069833096082950" class="gsc_a_ac gs_ibl">116</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:5nxA0vEk-isC" class="gsc_a_at">In vitro and in vivo antitumor effects of bisphosphonates</a><div class="gs_gray">P Clézardin, P Fournier, S Boissier, O Peyruchaud</div><div class="gs_gray">Current medicinal chemistry 10 (2), 173-180<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1741299263719489314" class="gsc_a_ac gs_ibl">110</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:fEOibwPWpKIC" class="gsc_a_at">Complex formation of human thrombospondin with osteonectin</a><div class="gs_gray">P CLEZARDIN, L MALAVAL, AS EHRENSPERGER, PD DELMAS, ...</div><div class="gs_gray">European journal of biochemistry 175 (2), 275-284<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12061289492825917634" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">Therapeutic targets for bone metastases in breast cancer</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Breast Cancer Research 13 (2), 1-9<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13215895828033427182" class="gsc_a_ac gs_ibl">108</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:XiSMed-E-HIC" class="gsc_a_at">The antitumor potential of bisphosphonates.</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Seminars in oncology 29 (6 Suppl 21), 33-42<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7658804917211735859" class="gsc_a_ac gs_ibl">105</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:J-pR_7NvFogC" class="gsc_a_at">Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells</a><div class="gs_gray">A Bellahcene, R Bachelier, C Detry, R Lidereau, P Clezardin, ...</div><div class="gs_gray">Breast cancer research and treatment 101 (2), 135-148<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8960905078199257345" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity</a><div class="gs_gray">O Peyruchaud, CM Serre, R NicAmhlaoibh, P Fournier, P Clézardin</div><div class="gs_gray">Journal of Biological Chemistry 278 (46), 45826-45832<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16415786857154814218" class="gsc_a_ac gs_ibl">103</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:OR75R8vi5nAC" class="gsc_a_at">One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion-exchange&nbsp;…</a><div class="gs_gray">P Clezardin, JL McGregor, M Manach, H Boukerche, M Dechevanne</div><div class="gs_gray">Journal of Chromatography A 319, 67-77<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7343490571213234819" class="gsc_a_ac gs_ibl">100</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:4MWp96NkSFoC" class="gsc_a_at">Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo</a><div class="gs_gray">PD Ottewell, B Deux, H Mönkkönen, S Cross, RE Coleman, P Clezardin, ...</div><div class="gs_gray">Clinical Cancer Research 14 (14), 4658-4666<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13457635263793836769" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:geHnlv5EZngC" class="gsc_a_at">Nitrogen-containing bisphosphonates can inhibit angiogenesis <i>in vivo</i> without the involvement of farnesyl pyrophosphate synthase</a><div class="gs_gray">V Stresing, PG Fournier, A Bellahcène, I Benzaïd, H Mönkkönen, ...</div><div class="gs_gray">Bone 48 (2), 259-266<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8208952076580327439" class="gsc_a_ac gs_ibl">96</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">Cathepsin K inhibitors as treatment of bone metastasis</a><div class="gs_gray">C Le Gall, E Bonnelye, P Clézardin</div><div class="gs_gray">Current opinion in supportive and palliative care 2 (3), 218-222<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15920299328867543043" class="gsc_a_ac gs_ibl">90</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes</a><div class="gs_gray">M Croset, F Pantano, CWS Kan, E Bonnelye, F Descotes, ...</div><div class="gs_gray">Cancer research 78 (18), 5259-5273<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6672406194231612379" class="gsc_a_ac gs_ibl">89</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:_axFR9aDTf0C" class="gsc_a_at">Increased expression and serum levels of the stromal cell‐secreted protein periostin in breast cancer bone metastases</a><div class="gs_gray">S Contié, N Voorzanger‐Rousselot, J Litvin, P Clézardin, P Garnero</div><div class="gs_gray">International journal of cancer 128 (2), 352-360<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16660013793912096618" class="gsc_a_ac gs_ibl">89</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Human breast tumors override the antiangiogenic effect of stromal thrombospondin‐1 in vivo</a><div class="gs_gray">A Fontana, S Filleur, J Guglielmi, L Frappart, G Bruno‐Bossio, S Boissier, ...</div><div class="gs_gray">International journal of cancer 116 (5), 686-691<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11029718274609610929" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">Decorin inhibits cell attachment to thrombospondin‐1 by binding to a KKTR‐dependent cell adhesive site present within the N‐terminal domain of thrombospondin‐1</a><div class="gs_gray">B Merle, L Malaval, J Lawler, P Delmas, P Clezardin</div><div class="gs_gray">Journal of cellular biochemistry 67 (1), 75-83<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13716999412133719596" class="gsc_a_ac gs_ibl">85</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:W5xh706n7nkC" class="gsc_a_at">Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs</a><div class="gs_gray">V Stresing, E Baltziskueta, N Rubio, J Blanco, MC Arriba, J Valls, M Janier, ...</div><div class="gs_gray">Oncogene 32 (6), 724-735<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11340185185247063313" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival</a><div class="gs_gray">M Raphaël, V Lehen’kyi, M Vandenberghe, B Beck, S Khalimonchyk, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 111 (37), E3870-E3879<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4496797799373172013" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Anti-tumour activity of zoledronic acid</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Cancer treatment reviews 31, 1-8<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15852384594256322923" class="gsc_a_ac gs_ibl">79</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">Cancer cell colonisation in the bone microenvironment</a><div class="gs_gray">C Kan, G Vargas, FL Pape, P Clézardin</div><div class="gs_gray">International journal of molecular sciences 17 (10), 1674<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17006556099775186268" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">How do bisphosphonates inhibit bone metastasis in vivo</a><div class="gs_gray">PG Fournier, V Stresing, FH Ebetino, P Clezardin</div><div class="gs_gray">Neoplasia 12 (7), 571-578<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10462701261510114919" class="gsc_a_ac gs_ibl">77</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:LhH-TYMQEocC" class="gsc_a_at">Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis</a><div class="gs_gray">P Clezardin, JL McGregor, M Dechavanne, KJ Clemetson</div><div class="gs_gray">British journal of haematology 60 (2), 331-344<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12766510141239128878" class="gsc_a_ac gs_ibl">76</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:SP6oXDckpogC" class="gsc_a_at">Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin</a><div class="gs_gray">A Fradet, H Sorel, L Bouazza, D Goehrig, B Dépalle, A Bellahcene, ...</div><div class="gs_gray">Cancer research 71 (17), 5728-5738<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7462132631820066583" class="gsc_a_ac gs_ibl">75</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:GtLg2Ama23sC" class="gsc_a_at">Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate</a><div class="gs_gray">M Colombel, S Filleur, P Fournier, C Merle, J Guglielmi, A Courtin, ...</div><div class="gs_gray">Cancer research 65 (1), 300-308<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17176800222448221181" class="gsc_a_ac gs_ibl">75</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells: A model to study the different effects of thrombospondin in cell adhesion</a><div class="gs_gray">P CLEZARDIN, H JOUISHOMME, P CHAVASSIEUX, PJ MARIE</div><div class="gs_gray">European journal of biochemistry 181 (3), 721-726<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5357316600002426038" class="gsc_a_ac gs_ibl">75</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:ye4kPcJQO24C" class="gsc_a_at">Advances in optical imaging and novel model systems for cancer metastasis research</a><div class="gs_gray">NV Henriquez, PGM van Overveld, I Que, JT Buijs, R Bachelier, EL Kaijzel, ...</div><div class="gs_gray">Clinical &amp; experimental metastasis 24 (8), 699-705<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10603871890002011109" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:BqipwSGYUEgC" class="gsc_a_at">International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients</a><div class="gs_gray">JJ Body, R Coleman, P Clezardin, C Ripamonti, R Rizzoli, M Aapro</div><div class="gs_gray">European Journal of Cancer 43 (5), 852-858<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4744856098439496056" class="gsc_a_ac gs_ibl">70</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation <i>in vivo</i></a><div class="gs_gray">B Gibert, B Eckel, V Gonin, D Goldschneider, J Fombonne, B Deux, ...</div><div class="gs_gray">British journal of cancer 107 (1), 63-70<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5291582190753734147" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Mechanisms of action of bisphosphonates in oncology: a scientific concept evolving from antiresorptive to anticancer activities</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">BoneKEy reports 2<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4376745240881125445" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:ldfaerwXgEUC" class="gsc_a_at">Localization of platelet osteonectin at the internal face of the alpha-granule membranes in platelets and megakaryocytes</a><div class="gs_gray">J Breton-Gorius, P Clezardin, J Guichard, N Debili, L Malaval, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5582022616872943902" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Bone-targeted therapies in cancer-induced bone disease</a><div class="gs_gray">S Sousa, P Clézardin</div><div class="gs_gray">Calcified tissue international 102 (2), 227-250<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5982632278373619323" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases</a><div class="gs_gray">M Colombel, CL Eaton, F Hamdy, E Ricci, G van der Pluijm, M Cecchini, ...</div><div class="gs_gray">The Prostate 72 (7), 713-720<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6971781240336787295" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Bisphosphonates in preclinical bone oncology</a><div class="gs_gray">P Clézardin, I Benzaïd, PI Croucher</div><div class="gs_gray">Bone 49 (1), 66-70<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1991945662419059104" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:ZeXyd9-uunAC" class="gsc_a_at"><i>TWIST1</i> Expression in Breast Cancer Cells Facilitates Bone Metastasis Formation</a><div class="gs_gray">M Croset, D Goehrig, A Frackowiak, E Bonnelye, S Ansieau, A Puisieux, ...</div><div class="gs_gray">Journal of Bone and Mineral Research 29 (8), 1886-1899<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2887063021101898465" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and&nbsp;…</a><div class="gs_gray">M David, J Ribeiro, F Descotes, CM Serre, M Barbier, M Murone, ...</div><div class="gs_gray">International journal of oncology 40 (4), 1133-1141<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5344193915234184569" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis.</a><div class="gs_gray">P Clézardin, J Gligorov, P Delmas</div><div class="gs_gray">Joint Bone Spine 67 (1), 22-29<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2398664387698360255" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">The role of osteoclasts in breast cancer bone metastasis</a><div class="gs_gray">F Le Pape, G Vargas, P Clézardin</div><div class="gs_gray">Journal of bone oncology 5 (3), 93-95<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17507827471519837309" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">A convenient clinically relevant model of human breast cancer bone metastasis</a><div class="gs_gray">T Garcia, A Jackson, R Bachelier, P Clément-Lacroix, R Baron, ...</div><div class="gs_gray">Clinical &amp; experimental metastasis 25 (1), 33-42<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11355912745150496124" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:vbGhcppDl1QC" class="gsc_a_at">In vivo phosphoantigen levels in bisphosphonate-treated human breast tumors trigger Vγ9Vδ2 T-cell antitumor cytotoxicity through ICAM-1 engagement</a><div class="gs_gray">I Benzaïd, H Mönkkönen, E Bonnelye, J Mönkkönen, P Clézardin</div><div class="gs_gray">Clinical Cancer Research 18 (22), 6249-6259<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13561206830314933407" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:N5tVd3kTz84C" class="gsc_a_at">Platelet‐osteosarcoma cell interaction is mediated through a specific fibrinogen‐binding sequence located within the N‐terminal domain of thrombospondin 1</a><div class="gs_gray">C Voland, CM Serre, P Delmas, P Clézardin</div><div class="gs_gray">Journal of Bone and Mineral Research 15 (2), 361-368<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10658544129698581521" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:bnK-pcrLprsC" class="gsc_a_at">Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms</a><div class="gs_gray">A Boucharaba, B Guillet, F Menaa, M Hneino, AJ Van Wijnen, P Clézardin, ...</div><div class="gs_gray">Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 18&nbsp;…<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9263281967699291340" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Transmigration: a new property of mature multinucleated osteoclasts</a><div class="gs_gray">F Saltel, A Chabadel, Y Zhao, MH Lafage‐Proust, P Clézardin, P Jurdic, ...</div><div class="gs_gray">Journal of bone and mineral research 21 (12), 1913-1923<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9123485813393049071" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Integrins in bone metastasis formation and potential therapeutic implications</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">Current cancer drug targets 9 (7), 801-806<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10130282256858278387" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction</a><div class="gs_gray">P Clezardin, CM Serre, MC Trzeciak, J Drouin, PD Delmas</div><div class="gs_gray">Cancer research 51 (10), 2621-2627<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14896253597692812437" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer</a><div class="gs_gray">D Sahay, R Leblanc, TGP Grunewald, S Ambatipudi, J Ribeiro, ...</div><div class="gs_gray">Oncotarget 6 (24), 20604<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12060796323750244516" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:8AbLer7MMksC" class="gsc_a_at">Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity</a><div class="gs_gray">M David, I Machuca-Gayet, J Kikuta, P Ottewell, F Mima, R Leblanc, ...</div><div class="gs_gray">Journal of Biological Chemistry 289 (10), 6551-6564<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8413439824665546204" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Overexpression of CD9 in human breast cancer cells promotes the development of bone metastases</a><div class="gs_gray">P Kischel, A Bellahcene, B Deux, V Lamour, R Dobson, E De Pauw, ...</div><div class="gs_gray">Anticancer research 32 (12), 5211-5220<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3210684965359075149" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo</a><div class="gs_gray">PGJ Fournier, F Daubiné, MW Lundy, MJ Rogers, FH Ebetino, ...</div><div class="gs_gray">Cancer research 68 (21), 8945-8953<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8478817404131328649" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:uWiczbcajpAC" class="gsc_a_at">The molecular basis of bisphosphonate activity: a preclinical perspective</a><div class="gs_gray">J Green, P Clézardin</div><div class="gs_gray">Seminars in Oncology 37, S3-S11<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13092341389164527732" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Platelet is a major contributor to circulating levels of Dickkopf‐1: clinical implications in patients with multiple myeloma</a><div class="gs_gray">N Voorzanger‐Rousselot, D Goehrig, T Facon, P Clézardin, P Garnero</div><div class="gs_gray">British journal of haematology 145 (2), 264-266<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3875308954845898032" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:gsN89kCJA0AC" class="gsc_a_at">Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention</a><div class="gs_gray">F Daubiné, D Cortial, G Ladam, H Atmani, Y Haïkel, JC Voegel, ...</div><div class="gs_gray">Biomaterials 30 (31), 6367-6373<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14335014169446320038" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1</a><div class="gs_gray">P CLEZARDIN, J LAWLER, J AMIRAL, G QUENTIN, P DELMAS</div><div class="gs_gray">Biochemical Journal 321 (3), 819-827<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4680433260866582995" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:DUooU5lO8OsC" class="gsc_a_at">Characterization of two murine monoclonal antibodies (P10, P12) directed against different determinants on human blood platelet thrombospondin</a><div class="gs_gray">P CLEZARDIN, JL McGREGOR, M LYON, KJ CLEMETSON, J HUPPERT</div><div class="gs_gray">European journal of biochemistry 154 (1), 95-102<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17763677469111905840" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Lysyl oxidase is a strong determinant of tumor cell colonization in bone</a><div class="gs_gray">C Reynaud, L Ferreras, P Di Mauro, C Kan, M Croset, E Bonnelye, F Pez, ...</div><div class="gs_gray">Cancer research 77 (2), 268-278<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1392371440860098510" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">Isolation of thrombospondin released from thrombinstimulated human platelets by fast protein liquid chromatography on an anion-exchange mono-q column</a><div class="gs_gray">P Clezardin, JL McGregor, M Manach, F Robert, M Dechavanne, ...</div><div class="gs_gray">Journal of Chromatography A 296, 249-256<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15071084503075266903" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Nitrogen-containing bisphosphonates and cancer immunotherapy</a><div class="gs_gray">P Clézardin, M Massaia</div><div class="gs_gray">Current pharmaceutical design 16 (27), 3007-3014<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11673753383864410273" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression</a><div class="gs_gray">E Ricci, E Mattei, C Dumontet, CL Eaton, F Hamdy, G van der Pluije, ...</div><div class="gs_gray">The Prostate 73 (16), 1738-1746<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3703148167243204167" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Osteonectin is an α‐granule component involved with thrombospondin in platelet aggregation</a><div class="gs_gray">P Clezardin, L Malaval, MC Trzeciak, J Guichard, T Lecompte, MC Morel, ...</div><div class="gs_gray">Journal of Bone and Mineral Research 6 (10), 1059-1070<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1934555405924746362" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:i2xiXl-TujoC" class="gsc_a_at">The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Bulletin du cancer 98 (7), 837-846<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15835837157491668298" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Cell membrane proteomic analysis identifies proteins differentially expressed in osteotropic human breast cancer cells</a><div class="gs_gray">P Kischel, F Guillonneau, B Dumont, A Bellahcène, V Stresing, ...</div><div class="gs_gray">Neoplasia 10 (9), 1014-IN11<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7545677141008109202" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">Tumour-derived miRNAs and bone metastasis</a><div class="gs_gray">M Croset, C Kan, P Clezardin</div><div class="gs_gray">BoneKEy reports 4<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15755275859281276670" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:UebtZRa9Y70C" class="gsc_a_at">Thrombospondin in milk, other breast secretions, and breast tissue</a><div class="gs_gray">J Dawes, P Clezardin, DA Pratt</div><div class="gs_gray">Seminars in thrombosis and hemostasis 13 (03), 378-384<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1480490856254338431" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis</a><div class="gs_gray">N Santana-Codina, R Carretero, R Sanz-Pamplona, T Cabrera, E Guney, ...</div><div class="gs_gray">Molecular &amp; Cellular Proteomics 12 (8), 2111-2125<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12133567291385865701" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis</a><div class="gs_gray">B Dumont, V Castronovo, O Peulen, N Blétard, P Clézardin, P Delvenne, ...</div><div class="gs_gray">Journal of proteome research 11 (4), 2247-2260<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8193821523355032131" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:olpn-zPbct0C" class="gsc_a_at">Potential anticancer properties of bisphosphonates: insights from preclinical studies</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal&nbsp;…<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9341686998530184030" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Structural and immunological comparison of human thrombospondins isolated from platelets and from culture supernatants of endothelial cells and fibroblasts: Evidence for a&nbsp;…</a><div class="gs_gray">P CLEZARDIN, NR HUNTER, JW LAWLER, DA PRATT, JL McGREGOR, ...</div><div class="gs_gray">European journal of biochemistry 159 (3), 569-579<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7067306472166006921" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ZL2owqcAAAAJ:M05iB0D1s5AC" class="gsc_a_at">Emerging therapies in bone metastasis</a><div class="gs_gray">L Clément-Demange, P Clézardin</div><div class="gs_gray">Current opinion in pharmacology 22, 79-86<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5725103206084246185" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:tuHXwOkdijsC" class="gsc_a_at">Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC)</a><div class="gs_gray">CB Confavreux, N Girard, JB Pialat, PP Bringuier, ...</div><div class="gs_gray">BoneKEy reports 3<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14974623682880193613" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:ODE9OILHJdcC" class="gsc_a_at">Tandem purification of IgM monoclonal antibodies from mouse ascites fluids by anion-exchange and gel fast protein liquid chromatography</a><div class="gs_gray">P Clezardin, G Bougro, JL McGregor</div><div class="gs_gray">Journal of Chromatography A 354, 425-433<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7010019063588466124" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:OTTXONDVkokC" class="gsc_a_at">Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers</a><div class="gs_gray">L Chambard, N Girard, E Ollier, JC Rousseau, F Duboeuf, MC Carlier, ...</div><div class="gs_gray">Bone 108, 202-209<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15061506552990980966" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:08ZZubdj9fEC" class="gsc_a_at">Pathophysiology of bone metastases from solid malignancies</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Joint Bone Spine 84 (6), 677-684<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7883756544084418945" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:GnPB-g6toBAC" class="gsc_a_at">Development of a new ELISA for serum periostin: evaluation of growth-related changes and bisphosphonate treatment in mice</a><div class="gs_gray">S Contié, N Voorzanger-Rousselot, J Litvin, N Bonnet, S Ferrari, ...</div><div class="gs_gray">Calcified tissue international 87 (4), 341-350<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4777713979007084632" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:hkOj_22Ku90C" class="gsc_a_at">A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer</a><div class="gs_gray">A Fradet, H Sorel, B Depalle, CM Serre, D Farlay, A Turtoi, A Bellahcene, ...</div><div class="gs_gray">PloS one 8 (9), e75092<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11024611952928567805" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:p2g8aNsByqUC" class="gsc_a_at">Localization of thrombospondin, CD36 and CD51 during prenatal development of the human mammary gland</a><div class="gs_gray">C Pechoux, P Clezardin, R Dante, CM Serre, M Clerget, N Bertin, J Lawler, ...</div><div class="gs_gray">Differentiation 57 (2), 133-141<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7549702356584233354" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Combination of anti‐angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis</a><div class="gs_gray">R Bachelier, CB Confavreux, O Peyruchaud, M Croset, D Goehrig, ...</div><div class="gs_gray">International journal of cancer 135 (6), 1319-1329<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6174304733236441494" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Identification of Heparin-Binding EGF-Like Growth Factor (HB-EGF) as a Biomarker for Lysophosphatidic Acid Receptor Type 1 (LPA<sub>1</sub>) Activation in Human Breast&nbsp;…</a><div class="gs_gray">M David, D Sahay, F Mege, F Descotes, R Leblanc, J Ribeiro, P Clézardin, ...</div><div class="gs_gray">PLoS One 9 (5), e97771<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10918687768818561388" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:M7yex6snE4oC" class="gsc_a_at">Role of Platelet Membrane Glycoproteins Ib/IX and Ilb/IIIa, and of Platelet α-Granule Proteins in Platelet Aggregation Induced by Human Osteosarcoma Cells</a><div class="gs_gray">P Clezardin, J Drouin, MC Morel-Kopp, M Hanss, B Kehrel, CM Serre, ...</div><div class="gs_gray">Cancer research 53 (19), 4695-4700<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15536715279731773450" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Low-intensity ultrasound promotes clathrin-dependent endocytosis for drug penetration into tumor cells</a><div class="gs_gray">S Tardoski, E Gineyts, J Ngo, A Kocot, P Clézardin, D Melodelima</div><div class="gs_gray">Ultrasound in medicine &amp; biology 41 (10), 2740-2754<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11744094317454301223" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:IUKN3-7HHlwC" class="gsc_a_at">Expression and localisation of αv integrins in human odontoblasts</a><div class="gs_gray">MJ Staquet, ML Couble, A Romeas, M Connolly, H Magloire, RO Hynes, ...</div><div class="gs_gray">Cell and tissue research 323 (3), 457-463<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=381850640067855290" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">CD36 mediates binding of soluble thrombospondin‐1 but not cell adhesion and haptotaxis on immobilized thrombospondin‐1</a><div class="gs_gray">S Magnetto, G Bruno‐Bossio, C Voland, J Lecerf, J Lawler, P Delmas, ...</div><div class="gs_gray">Cell Biochemistry and Function: Cellular biochemistry and its modulation by&nbsp;…<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13374486203333086565" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Evidence from Moiré patterns of packing faults in boron nitride crystals</a><div class="gs_gray">JF Goodman</div><div class="gs_gray">Nature 180 (4583), 425-427<span class="gs_oph">, 1957</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17730770641484588576" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1957</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Identification and characterization of fragments of major glycoproteins from platelet membrane after chymotrypsin treatment</a><div class="gs_gray">JL McGREGOR, P CLEZARDIN, E JAMES, L McGREGOR, ...</div><div class="gs_gray">European journal of biochemistry 148 (1), 97-106<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2767501624634925426" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors</a><div class="gs_gray">G Vargas, M Bouchet, L Bouazza, P Reboul, C Boyault, M Gervais, C Kan, ...</div><div class="gs_gray">Oncogene 38 (7), 950-964<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8168113660992267730" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Overexpression of a functional calcium-sensing receptor dramatically increases osteolytic potential of MDA-MB-231 cells in a mouse model of bone metastasis through epiregulin&nbsp;…</a><div class="gs_gray">C Boudot, L Hénaut, U Thiem, S Geraci, M Galante, P Saldanha, Z Saidak, ...</div><div class="gs_gray">Oncotarget 8 (34), 56460<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3452416330693361412" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:EkHepimYqZsC" class="gsc_a_at">Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone</a><div class="gs_gray">A Fradet, M Bouchet, C Delliaux, M Gervais, C Kan, C Benetollo, ...</div><div class="gs_gray">Oncotarget 7 (47), 77071<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12978162554226635394" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">Distribution of thrombospondin and integrin α v in DCIS, invasive ductal and lobular human breast carcinomas</a><div class="gs_gray">CM Serre, G Boivin, P Clezardin, PD Delmas, L Frappart</div><div class="gs_gray">Virchows Archiv 427 (4), 365-372<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9798584839563526196" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:GFxP56DSvIMC" class="gsc_a_at">Tandem purification of mouse IgM monoclonal atibodies produced in vitro using anion-exchange and gel fast protein liquid chromatography</a><div class="gs_gray">P Clezardin, NR Hunter, IR MacGregor, JL MacGregor, DS Pepper, ...</div><div class="gs_gray">Journal of Chromatography A 358, 209-218<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17538758575737119993" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Tryptic peptide map analysis of the major human blood platelet membrane glycoproteins separated by two-dimensional polyacrylamide gel electrophoresis</a><div class="gs_gray">JL McGregor, KJ Clemetson, E James, P Clezardin, M Dechavanne, ...</div><div class="gs_gray">Biochimica et Biophysica Acta (BBA)-Biomembranes 689 (3), 513-522<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10038876693751160195" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">The RANK–RANKL axis: an opportunity for drug repurposing in cancer?</a><div class="gs_gray">S Peters, P Clézardin, I Márquez-Rodas, D Niepel, C Gedye</div><div class="gs_gray">Clinical and Translational Oncology, 1-15<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3307480493756461549" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Thrombospondin (TSP1) mediates in vitro proliferation of human MG‐63 osteoblastic cells induced by α‐thrombin</a><div class="gs_gray">Z Abbadia, P Clezardin, CM Serre, J Amiral, PD Delmas</div><div class="gs_gray">FEBS letters 329 (3), 341-346<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9315238120931132195" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Bone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma</a><div class="gs_gray">E Terpos, CB Confavreux, P Clezardin</div><div class="gs_gray">BoneKEy reports 4<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12734450635988243355" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Zoledronic acid inhibits in vivo experimental angiogenesis</a><div class="gs_gray">S Boissier, M Colombel, P Delmas, F Cabon, P Clézardin</div><div class="gs_gray">Bone 30 (3), 38S-38S<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=372240061463674325" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Aul-kAQHnToC" class="gsc_a_at">PART B. EXPRESSION OF THROMBOSPONDIN BY CELLS IN CULTURE</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">Thrombospondin, 41<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15485231932473114007,499197356813913050" class="gsc_a_ac gs_ibl">15</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="ZL2owqcAAAAJ:Aul-kAQHnToC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">TMPRSS2: ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases</a><div class="gs_gray">C Delliaux, TV Tian, M Bouchet, A Fradet, N Vanpouille, A Flourens, ...</div><div class="gs_gray">Cancer letters 438, 32-43<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16410881912047897135" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Unseeded inertial cavitation for enhancing the delivery of chemotherapies: a safety study</a><div class="gs_gray">M Lafond, JL Mestas, F Prieur, K Chettab, S Geraci, P Clézardin, C Lafon</div><div class="gs_gray">Ultrasound in medicine &amp; biology 42 (1), 220-231<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6062439802598785507" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:F9fV5C73w3QC" class="gsc_a_at">Tandem separation of labelled human blood platelet membrane glycoproteins by anion-exchange and gel fast protein liquid chromatography</a><div class="gs_gray">JL McGregor, P Clezardin, M Manach, M Dechavanne</div><div class="gs_gray">Journal of Chromatography A 326, 179-190<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14485045602191752119" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">The CaSR in pathogenesis of breast cancer: a new target for early stage bone metastases</a><div class="gs_gray">S Das, P Clézardin, S Kamel, M Brazier, R Mentaverri</div><div class="gs_gray">Frontiers in oncology 10, 69<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=744034945915297328" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Low-intensity continuous ultrasound triggers effective bisphosphonate anticancer activity in breast cancer</a><div class="gs_gray">S Tardoski, J Ngo, E Gineyts, JP Roux, P Clézardin, D Melodelima</div><div class="gs_gray">Scientific reports 5 (1), 1-15<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4883992172832624324" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:otzGkya1bYkC" class="gsc_a_at">Non‐coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance</a><div class="gs_gray">M Puppo, H Taipaleenmäki, E Hesse, P Clézardin</div><div class="gs_gray">British journal of pharmacology 178 (9), 1936-1954<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3691841825229989538" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Models of human platelet thrombospondin in solution. A dynamic light-scattering study</a><div class="gs_gray">L Vuillard, P Clezardin, A Miller</div><div class="gs_gray">Biochemical journal 275 (1), 263-266<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=257094578557087594" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Rapid purification and partial characterization of human platelet glycoprotein IIIb</a><div class="gs_gray">JL MacGregor, B Catimel, S Parmentier, P Clezardin, M Dechavanne, ...</div><div class="gs_gray">J. Biol. Chem 264 (5), 501-506<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11195179776618999962" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:EYYDruWGBe4C" class="gsc_a_at">Cell attachment and fibrinogen binding properties of platelet and endothelial cell thrombospondin are not affected by structural differences in the 70 and 18 kDa protease&nbsp;…</a><div class="gs_gray">P Clezardin, MC Bourdillon, NR Hunter, JL McGregor</div><div class="gs_gray">FEBS letters 228 (2), 215-218<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13626951400405119593" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:NhqRSupF_l8C" class="gsc_a_at">Structural and immunological differences between human platelet and endothelial thrombospondins</a><div class="gs_gray">P Clezardin, NR Hunter, JL McGregor, DS Pepper, J Dawes</div><div class="gs_gray">FEBS letters 196 (1), 49-53<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6828071183536075602" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Bone metastases in the era of targeted treatments: insights from molecular biology</a><div class="gs_gray">J Dewulf, C Vangestel, Y Verhoeven, P van Dam, F Elvas, ...</div><div class="gs_gray">The Quarterly Journal of Nuclear Medicine and Molecular Imaging 63 (2), 98-111<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3182005278821787776" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:DJbcl8HfkQkC" class="gsc_a_at">The C-terminal intact forms of periostin (iPTN) are surrogate markers for osteolytic lesions in experimental breast cancer bone metastasis</a><div class="gs_gray">E Gineyts, N Bonnet, C Bertholon, M Millet, A Pagnon-Minot, O Borel, ...</div><div class="gs_gray">Calcified tissue international 103 (5), 567-580<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2632909320169535904" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:a0OBvERweLwC" class="gsc_a_at">Pathophysiology of bone metastases and new molecular targets involved in bone remodelling</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Bulletin du cancer 100 (11), 1083-1091<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6339017762354664923" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Vital stain to study cell invasion in modified Boyden chamber assay</a><div class="gs_gray">MR Vipra, JM Chiplonkar</div><div class="gs_gray">BioTechniques 33 (6), 1200-1204<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7018139893451531885" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Nanoscale stiffness distribution in bone metastasis</a><div class="gs_gray">L Richert, L Keller, Q Wagner, F Bornert, C Gros, S Bahi, F Clauss, ...</div><div class="gs_gray">Scientific Research<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1039652575015214404" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Targeting breast cancer osteomimetic genes by microRNAs-30 decreases the formation of metastatic osteolytic lesions in mice</a><div class="gs_gray">M Croset, R Bachelier, N Allioli, SS Hong, R Agami, P Clézardin</div><div class="gs_gray">Bulletin du Cancer 98, S29-S30<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=489084471744142432" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:gVv57TyPmFsC" class="gsc_a_at">Bone hyperresorption in bone metastases</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Presse medicale (Paris, France: 1983) 29 (9), 487-491<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14442265583780860789" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Mécanismes d'action des bisphosphonates sur les cellules tumorales et perspectives d'utilisation dans le traitement de l'ostéolyse maligne</a><div class="gs_gray">P Clézardin, J Gligorov, P Delmas</div><div class="gs_gray">Revue du rhumatisme 67 (1), 28-36<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8635985198574554365" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">The growth-supportive effect of thrombospondin (TSP1) and the expression of TSP1 by human MG-63 osteoblastic cells are both inhibited by dexamethasone</a><div class="gs_gray">Z Abbadia, J Amiral, MC Trzeciak, PD Delmas, P Clezardin</div><div class="gs_gray">FEBS letters 335 (2), 161-166<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11342365929063862356" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">Bone metastasis: Mechanisms, therapies, and biomarkers</a><div class="gs_gray">P Clézardin, R Coleman, M Puppo, P Ottewell, E Bonnelye, F Paycha, ...</div><div class="gs_gray">Physiological Reviews 101 (3), 797-855<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8892344609319622862" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions</a><div class="gs_gray">F Pantano, M Croset, K Driouch, N Bednarz-Knoll, M Iuliani, G Ribelli, ...</div><div class="gs_gray">Oncogene 40 (7), 1284-1299<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15640272991653633574" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:SdhP9T11ey4C" class="gsc_a_at">Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced Vγ9Vδ2 T cell cytotoxicity in PC-3 prostate cancer cells</a><div class="gs_gray">S Arkko, HP Zlatev, H Mönkkönen, J Räikkönen, I Benzaid, P Clezardin, ...</div><div class="gs_gray">Cancer letters 357 (1), 279-285<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10273374155894250448" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:0N-VGjzr574C" class="gsc_a_at">Insights into the Antitumor Effects of Bisphosphonates from Preclinical Models and Potential Clinical Implications.</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">IBMS BoneKEy<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16329771516224766148" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Oligometastatic bone disease. Can limited metastatic bone disease be cured? Is there room for local ablative treatments?</a><div class="gs_gray">J Thariat, A Leysalle, S Vignot, PY Marcy, A Lacout, G Bera, JL Lagrange, ...</div><div class="gs_gray">Cancer radiotherapie: journal de la Societe francaise de radiotherapie&nbsp;…<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2611597179103151019" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:TQgYirikUcIC" class="gsc_a_at">Nitrogen-Containing Bisphosphonates and Human γδ T Cells.</a><div class="gs_gray">I Benzaid, P Clézardin</div><div class="gs_gray">IBMS BoneKEy 7 (6)<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3461591599678235205" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:dshw04ExmUIC" class="gsc_a_at">Zoledronate-induced IPP/ApppI (phosphoantigen) accumulation in human breast cancer cells correlates with Vγ9Vδ2 T cell-mediated cancer cell death in vitro and in vivo</a><div class="gs_gray">I Benzaid, H Mönkkönen, V Stresing, E Bonnelye, J Green, J Mönkkönen, ...</div><div class="gs_gray">Bone, S43<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7447243819411145498" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:rO6llkc54NcC" class="gsc_a_at">Lysophosphatidic acid: a new link between blood platelets and bone metastasis</a><div class="gs_gray">O Peyruchaud, A Boucharaba, JS Saulnier-Blache, P Clézardin</div><div class="gs_gray">Medecine Sciences: M/S 21 (4), 353-355<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6069920144201389921" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:IaI1MmNe2tcC" class="gsc_a_at">MicroRNAs and Their Roles in Breast Cancer Bone Metastasis</a><div class="gs_gray">M Puppo, MK Valluru, P Clézardin</div><div class="gs_gray">Current osteoporosis reports, 1-8<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5615366136083481147" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Identification of cytoplasmic and membrane platelet glycoproteins using a combination of SDS-polyacrylamide gel electrophoresis and 125I-labelled lectins</a><div class="gs_gray">P Clezardin, JL McGregor, E James, M Dechavanne, KJ Clemetson</div><div class="gs_gray">Volume 2 Proceedings of the Second Symposium Lyon, France, June 27–30, 1983&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17456650347839564896" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:5MTHONV0fEkC" class="gsc_a_at">Comparative study of neoadjuvant chemotherapy with and without Zometa for management of locally advanced breast cancer with serum VEGF as primary endpoint: the NEOZOL Study</a><div class="gs_gray">L Lelièvre, P Clézardin, L Magaud, L Roche, N Tubiana-Mathieu, ...</div><div class="gs_gray">Clinical breast cancer 18 (6), e1311-e1321<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3006140962221489316" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">Physiopathologie des métastases osseuses des tumeurs solides</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Revue du rhumatisme monographies 84 (2), 107-114<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=544775400199798029" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:-FonjvnnhkoC" class="gsc_a_at">Traitement local ablatif de la maladie oligométastatique osseuse (hors chirurgie)</a><div class="gs_gray">J Thariat, A Leysalle, S Vignot, PY Marcy, A Lacout, G Bera, JL Lagrange, ...</div><div class="gs_gray">Cancer/Radiothérapie 16 (5-6), 330-338<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15663664668533831221" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:VLnqNzywnoUC" class="gsc_a_at">Thrombospondins, tumor angiogenesis and breast cancer</a><div class="gs_gray">P Clezardin, G Bruno-Bossio, A Fontana, CM Serre, S Magnetto, ...</div><div class="gs_gray">Pathologie-biologie 47 (4), 368-374<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12169566111814359704" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Production, characterization, and use of monoclonal antibodies directed against human blood platelet thrombospondin: immunologic comparison with human endothelial and&nbsp;…</a><div class="gs_gray">P Clezardin, NR Hunter, J Lawler, J Dawes, JL McGregor</div><div class="gs_gray">Seminars in thrombosis and hemostasis 13 (03), 261-275<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18131485964573192468" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis</a><div class="gs_gray">N Hinz, A Baranowsky, M Horn, M Kriegs, F Sibbertsen, DJ Smit, ...</div><div class="gs_gray">Cells 10 (2), 430<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4088862649009059841" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:BzfGm06jWhQC" class="gsc_a_at">ERRα expression in bone metastases leads to an exacerbated antitumor immune response</a><div class="gs_gray">M Bouchet, A Lainé, C Boyault, M Proponnet-Guerault, E Meugnier, ...</div><div class="gs_gray">Cancer research 80 (13), 2914-2926<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9962065844305321376" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:43bX7VzcjpAC" class="gsc_a_at">Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo [a] pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay</a><div class="gs_gray">CF Donini, M El Helou, A Wierinckx, B Győrffy, S Aires, A Escande, ...</div><div class="gs_gray">Frontiers in oncology 10, 712<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4165618517252924853" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:f2IySw72cVMC" class="gsc_a_at">Effect of intra-tibial injection on mechanical properties of mouse bone</a><div class="gs_gray">B Delpuech, C Confavreux, L Bouazza, S Geraci, P Clezardin, D Mitton, ...</div><div class="gs_gray">Computer methods in BiomeChaniCs and BiomediCal engineering 20 (sup1), S57-S58<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6436243622701398115" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:zCSUwVk65WsC" class="gsc_a_at">International society for therapeutic ultrasound conference 2016</a><div class="gs_gray">B Fowlkes, P Ghanouni, N Sanghvi, C Coussios, PC Lyon, M Gray, ...</div><div class="gs_gray">Journal of Therapeutic Ultrasound 5 (1), 1-114<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2245324203559576510" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Abstract P6-13-19: adding zoledronic acid to neo-adjuvant chemotherapy may improve the efficiency of chemotherapy in locally advanced breast cancer: results from the&nbsp;…</a><div class="gs_gray">P Mathevet, L Magaud, P Clézardin</div><div class="gs_gray">Cancer Research 76 (4 Supplement), P6-13-19-P6-13-19<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12448831892823372552" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?</a><div class="gs_gray">V Amoroso, F Petrelli, R Pedersini, EL Simoncini, P Clézardin, S Barni, ...</div><div class="gs_gray">Future Oncology 11 (21), 2853-2856<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17111394653104637662" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:ipzZ9siozwsC" class="gsc_a_at">Physiopathologie des métastases osseuses et nouvelles cibles moléculaires impliquées dans le remodelage osseux</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Bulletin du cancer 100 (11), 1083-1091<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12744555224611737096" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">Early bone metastasis-associated molecular and cellular events</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Bone Cancer, 41-45<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12698207554997941738" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:hMod-77fHWUC" class="gsc_a_at">Physiopathologie des métastases osseuses</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">oncologie 11 (1), 10-15<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4610505817079193339" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Frequent low-dose bisphosphonate therapy.</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Bone 41 (5), 901-902<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16569321270124566265" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:r0BpntZqJG4C" class="gsc_a_at">Does tumor angiogenesis play a role in bone metastatic process?</a><div class="gs_gray">O Peyruchaud, CM Serre, R NicAmhlaoibh, C Sveigaard, P Clézardin</div><div class="gs_gray">Revue medicale de la Suisse romande 124 (2), 83-84<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3823314806933119403" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:-f6ydRqryjwC" class="gsc_a_at">Bisphosphonates et métastases osseuses des tumeurs solides: intérêt thérapeutique au-delà de l'activité anti-ostéolytique</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">Progrès en urologie (Paris) 13 (2), 28-35<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10122817837204737637" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Thrombospondin induces the proliferation of rat calvaria osteoblastic cells</a><div class="gs_gray">M Hott, P Clezardin, PJ Marie</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 7, S213-S213<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5810287333884455379" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Characterization of Monoclonal Antibodies Specific for a High Molecular Weight Glycoprotein Secreted from Activated Human Blood Platelets</a><div class="gs_gray">P Clezardin, JL McGregor, M Lyon, HZ Shao, H Boukerche, KJ Clemetson, ...</div><div class="gs_gray">Protides of the Biological Fluids 32, 815-820<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1586247958725993078" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">Os, cible thérapeutique (RPC 2013)</a><div class="gs_gray">MH Vieillard, J Chiras, P Clézardin, JM Ferrero, J Barrière, P Beuzeboc</div><div class="gs_gray">Oncologie 15 (12), 673-686<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16318355386718552707" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Pourquoi certains cancers métastasent-ils préférentiellement à l’os?</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Oncologie 14 (1), 31-36<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12412021926674313373" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:_xSYboBqXhAC" class="gsc_a_at">1074 POSTER Effects of Zoledronic Acid and Denosumab on Human Vy9V62 T-cell-Mediated Cell Death of RANK-Expressing Breast Cancer Cells</a><div class="gs_gray">I Benzaïd, H Mönkkönen, P Clézardin</div><div class="gs_gray">European Journal of Cancer, S117<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6650734830485729213" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:umqufdRvDiIC" class="gsc_a_at">Antitumor properties of the bisphosphonate zoledronate and potential therapeutic implications in the clinic</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Bulletin du cancer 97 (8), 937-949<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17687711375049215370" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:k_IJM867U9cC" class="gsc_a_at">Editorial [Hot-topic: Molecularly Targeted Therapies in Breast Cancer Bone Metastases (Executive Editor: Philippe Clezardin)]</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">Current pharmaceutical design 16 (11), 1260-1261<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4192621875728480977" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Pathogénie des métastases osseuses</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Revue du rhumatisme (Ed. française) 75 (4), 327-331<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15134443958134010802" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:HtEfBTGE9r8C" class="gsc_a_at">The direct antitumor activity of bisphosphonates in vivo depends on their bone mineral affinity</a><div class="gs_gray">P Fournier, F Daubiné, MW Lundy, FH Ebetino, P Clézardin</div><div class="gs_gray">Bone 3 (38), 45<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17583337609492122443" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Prevention of breast cancer bone metastasis by an integrin alpha V beta 3 antagonist</a><div class="gs_gray">P Clezardin, P Ctement-Lacroix</div><div class="gs_gray">CANCER TREATMENT REVIEWS 32, S18-S18<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8827498081998169208" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:D_sINldO8mEC" class="gsc_a_at">Integrin alpha v beta 3 is critical for human breast cancer bone metastasis</a><div class="gs_gray">Y Zhao, P Fournier, CM Serre, A Boucharaba, J Guglielmi, O Peyruchaud, ...</div><div class="gs_gray">CANCER TREATMENT REVIEWS 31, S26-S26<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8642901687756568554" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:35N4QoGY0k4C" class="gsc_a_at">Bisphosphonates et cancer: mécanismes d'action et indications cliniques dans l'ostéolyse maligne</a><div class="gs_gray">J Gligorov, P Clézardin</div><div class="gs_gray">La Lettre du cancérologue (Boulogne) 9 (1), 36-44<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5384693755210397369" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:4hFrxpcac9AC" class="gsc_a_at">Clodronate selectively inhibits the attachment of highly metastatic prostate carcinoma cells to bone extracellular matrix.</a><div class="gs_gray">S Boissier, B Cuzin, PD Delmas, P Clezardin</div><div class="gs_gray">Bone 17 (6), 599-599<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17624037160193875583" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Rôle des ostéoclastes dans les mécanismes physiopathologiques de l'ostéolyse maligne</a><div class="gs_gray">P Clezardin, PD Delmas</div><div class="gs_gray">Bulletin du cancer. Supplément 80 (10), 11-15<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15254449882957310839" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">IDENTIFICATION AND CHARACTERIZATION OF FRAGMENTS OF MAJOR MEMBRANE-GLYCOPROTEINS REMAINING ON PLATELETS AFTER CHYMOTRYPSIN TREATMENT</a><div class="gs_gray">JL McGregor, P Clezardin, E James, L McGregor, M Dechavanne, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 50 (1), 187-187<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12674900869190664053" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">Influence of human cancer cell lines on mechanical properties of mice tibia</a><div class="gs_gray">M Gardegaront, G Plet, B Delpuech, L Bouazza, M Brevet, JB Pialat, ...</div><div class="gs_gray">Computer Methods in Biomechanics and Biomedical Engineering 23 (sup1), S115-S116<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16191269203726985479" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Failure prediction of tumoral bone with osteolytic lesion in mice</a><div class="gs_gray">B Delpuech, S Nicolle, CB Confavreux, L Bouazza, P Clezardin, D Mitton, ...</div><div class="gs_gray">Developments and Novel Approaches in Biomechanics and Metamaterials, 17-34<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13814631327984384570" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:FAceZFleit8C" class="gsc_a_at">ELISA MEASUREMENT OF CIRCULATING PERIOSTIN IN ANIMAL MODELS OF BONE LOSS OR BONE FORMATION AND IDENTIFICATION OF CIRCULATING AND TISSUE-SPECIFIC ASSOCIATED FORMS OF PERIOSTIN</a><div class="gs_gray">E Gineyts, N Bonnet, C Bertholon, A Pagnon-Minot, O Borel, D Hartmann, ...</div><div class="gs_gray">Osteoporosis International 27 (1), S207<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17228492369160903356" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Pathophysiology of bone metastases</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">ONCOLOGIE 17 (3), 69-74<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16202791211190775664" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Physiopathologie des métastases osseuses</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Oncologie 17 (3), 69-74<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7668132993080454751" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">MicroRNA-mediated regulation of bone metastasis formation: from primary tumors to skeleton</a><div class="gs_gray">M Croset, P Clézardin</div><div class="gs_gray">Bone Cancer, 479-489<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4292713058560602379" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:WZBGuue-350C" class="gsc_a_at">Disseminated tumor cell formation promoted by lysophosphatidic acid (LPA) involves ZEB1/miR21-dependent activation pathway</a><div class="gs_gray">D Sahay, R Leblanc, J Ribeiro, P Clézardin, O Peyruchaud</div><div class="gs_gray">Cancer Research 74 (19 Supplement), 1448-1448<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15598316535196690345" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">Methods and Pharmaceutical Compositions for the Treatment of Bone Density Related Diseases</a><div class="gs_gray">P Clezardin, V Gonin, R Bachelier, E Bonnelye</div><div class="gs_gray">US Patent App. 13/823,907<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3123043055409006042" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">Ectopic expression of twist-1 in breast cancer cells promotes bone metastasis formation</a><div class="gs_gray">M Croset, D Goehrig, S Ansieau, A Puisieux, PAR Clezardin</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 28<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14315152075978843938" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:mB3voiENLucC" class="gsc_a_at">RANK/RANKL pathway in cancer: Biological activity beyond bone?</a><div class="gs_gray">F Pantano, P Clézardin, D Santini</div><div class="gs_gray">Journal of bone oncology 1 (3), 67<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3243604766515827925" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Why do some cancers preferentially metastasize to bone?</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">Oncologie 14 (1), 31-36<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=137035352951589780" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">Rôle de la triade RANK/RANKL/ostéoprotégérine (OPG) dans les cancers primitifs et secondaires de l’os: aspects physiopathologiques et implications cliniques</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Bulletin du cancer 98 (7), 837-846<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17762682240940061955" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:sSrBHYA8nusC" class="gsc_a_at">Can bisphosphonates really reduce the risk of recurrences in early breast cancer?</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">IBMS BoneKEy 8, 159<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8197664822682368003" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">Interaction of autotaxin with breast cancer cell integrins might contribute to lysophosphatidic acid-mediated bone metastases</a><div class="gs_gray">M David, R Leblanc, B Deux, CM Serre, J Ribeiro, P Clézardin, ...</div><div class="gs_gray">Bone 1 (48), S39-S40<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15527968408959987026" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:dTyEYWd-f8wC" class="gsc_a_at">838 TESTING AND PROGNOSTIC IMPLICATIONS OF PROSTATE CANCER STEM CELLS IN BONE MARROW</a><div class="gs_gray">E Ricci, E Bourrelie, X Martin, C Dumontet, P Clezardin, G Thalmann, ...</div><div class="gs_gray">European Urology Supplements 2 (10), 265<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10216079398844795496" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Zoledronic acid-induced IPP/Apppl (phosphoantigen) accumulation in human breast cancer cells correlates with Vgamma9Vdelta2 T cell-mediated cancer cell death in vitro and in vivo</a><div class="gs_gray">I Benzaid, H Monkkonen, V Stresing, E Bonnelye, J Green, J Monkkonen, ...</div><div class="gs_gray">Bone 47, S266-S267<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17987590491021258845" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer</a><div class="gs_gray">A Fradet, H Sorel, B Deux, P Clézardin, E Bonnelye</div><div class="gs_gray">Bone 47, S289-S289<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13240240686345935056" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">Involvement of the Slit2/Robo1 Pathway in Breast Cancer Bone Metastasis</a><div class="gs_gray">V Gonin, R Bachelier, B Deux, S Contié, E Bonnelye, P Rabbitts, J Wu, ...</div><div class="gs_gray">Bone, S37<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8842307250948892816" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Expression of lyosophospholipase D/autotaxin by breast cancer cells controls bone metastasis formation by increasing osteoclast differentiation</a><div class="gs_gray">M David, E Wannecq, S Jansen, B Deux, J Ribeiro, CM Serre, S Grès, ...</div><div class="gs_gray">Bone, S41<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1931782584098811683" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">A cathepsin K inhibitor inhibits the progression of breast cancer bone metastases</a><div class="gs_gray">C Le Gall, J Gasser, E Bonnelye, J Zimmermann, P Clezardin</div><div class="gs_gray">Cancer treatment reviews 32, S16-S16<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18141609401998048478" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:MLfJN-KU85MC" class="gsc_a_at">Transcriptome analysis reveals an osteomimetic phenotype for human bone metastatic breast cancer cells</a><div class="gs_gray">A Bellahcene, C Detry, R Lidereau, P Clezardin, V Castronovo</div><div class="gs_gray">EJC Supplements 2 (4), 163<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15066031202843946389" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Antibody to rank ligand-Overview of RANK ligand</a><div class="gs_gray">P Fournier, FH Ebetino, A Bellahcene, V Castronovo, P Clezardin</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 20, P23-P24<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11785759560685943645" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:WqliGbK-hY8C" class="gsc_a_at">Use of analogs of risedronate to elucidate antitumor mechanisms of bisphosphonates in vivo</a><div class="gs_gray">PGJ Fournier, FH Ebetino, MW Lundy, P Clezardin</div><div class="gs_gray">CANCER TREATMENT REVIEWS 31, S36-S37<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10532152433528437308" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">A novel integrin antagonist: evaluation in bone growth tumor models</a><div class="gs_gray">J Guglielmi, I Pecheur, P Pujuguet, D Minet, R Baron, P Clement-Lacroix, ...</div><div class="gs_gray">CANCER TREATMENT REVIEWS 31, S16-S16<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8620717819293484969" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">Use of bisphosphonate analogs of risedronate to elucidate antitumor mechanisms of bisphosphonates in vivo.</a><div class="gs_gray">PG Fournier, MW Lundy, RH Ebetino, P Clezardin</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 19, S25-S25<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10645986370398723225" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">NE-10790, A PHOSPHONOCARBOXYLATE ANALOGUE OF THE BISPHOSPHONATE RISEDRONATE, EXHIBITS DIRECT ANTITUMOR ACTIVITY IN IN VIVO</a><div class="gs_gray">PG Fournier, MW Lundy, FH Ebetino, P Clezardin</div><div class="gs_gray">CALCIFIED TISSUE INTERNATIONAL 74, S43-S44<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5969950440634299940" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Bisphosphonates and bone metastases of solid tumors: therapeutic interest despite its anti-resorptive properties</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Progres en urologie: journal de l'Association francaise d'urologie et de la&nbsp;…<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10572593991395932329" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Effects of bisphosphonates zoledronic acid and risedronate on the growth of a human breast carcinoma cell line in vivo</a><div class="gs_gray">P Fournier, O Peyruchaud, L Frappart, CM Serre, S Boissier, P Delmas, ...</div><div class="gs_gray">Bone 30 (3), 40S-40S<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2277967319390145013" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">THROMBOSPONDIN MEDIATES PROLIFERATION OF HUMAN OSTEOBLASTIC CELLS INDUCED BY THROMBIN</a><div class="gs_gray">Z Abbadia, P Clezardin, C Serre, C Maillard, PD Delmas</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 7, S223-S223<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=964984398686641676" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:WbkHhVStYXYC" class="gsc_a_at">A POLYCLONAL ANTIBODY TO OSTEONECTIN INHIBITS COLLAGEN-INDUCED PLATELET-AGGREGATION AND CELL-SURFACE EXPRESSION OF ENDOGENOUS THROMBOSPONDIN</a><div class="gs_gray">P Clezardin, L Malaval, PD Delmas, C Kaplan</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 62 (1), 195-195<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7701202349760626684" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:fFSKOagxvKUC" class="gsc_a_at">Structural and immunological comparison of thrombospondin from platelets and colostrum</a><div class="gs_gray">P Clezardin, J Dawes</div><div class="gs_gray">THROMBOSIS RESEARCH, 55-55<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8369444641240996570" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:3htObqc8RwsC" class="gsc_a_at">CHARACTERIZATION OF AN ANTI-THROMBOSPONDIN MURINE MONOCLONAL-ANTIBODY (P8) THAT INHIBITS HUMAN-BLOOD PLATELET FUNCTIONS</a><div class="gs_gray">H Boukerche, JL MCGREGOR, L MCGREGOR, P Clezardin, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 54 (1), 218-218<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7498697894395023015" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">PURIFICATION OF THROMBOSPONDIN, FIBRONECTIN AND FIBRINOGEN BY FAST PROTEIN LIQUID-CHROMATOGRAPHY</a><div class="gs_gray">P Clezardin, JL McGregor, M Manach, M Dechavanne, KJ Clemetson</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 50 (1), 16-16<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7231447432079143014" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:FiytvqdAVhgC" class="gsc_a_at">Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma</a><div class="gs_gray">E Massy, JC Rousseau, M Gueye, E Bonnelye, M Brevet, L Chambard, ...</div><div class="gs_gray">Journal of Bone Oncology 29, 100364<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:1taIhTC69MYC" class="gsc_a_at">Exploring the significance of the exon 4-skipping isoform of the ZNF217 oncogene in breast cancer</a><div class="gs_gray">A Bellanger, DT Le, J Vendrell, A Wierinckx, LS Pongor, J Solassol, ...</div><div class="gs_gray">Frontiers in Oncology 11<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Serum total periostin is an independent marker of overall survival in non-small cell lung cancer</a><div class="gs_gray">JC Rousseau, E Massy, M Gueye, E Bonnelye, M Brevet, L Chambard, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 35, 103-103<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">Integrin alpha-5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions</a><div class="gs_gray">F Pantano, M Croset, K Driouch, N Bednarz-Knoll, M Iulialni, G Ribelli, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 35, 2-3<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Malignant assignment of neuronal Na+ leak channel, NALCN: governor of Ca2+ oscillations-encoded invadopodogenesis</a><div class="gs_gray">O Iamshanova, D Gordienko, A Folcher, A Bokhobza, G Shapovalov, ...</div><div class="gs_gray">bioRxiv<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Current and Emerging Bone-Targeted Therapies for The Treatment of Bone Metastases From Solid Tumors</a><div class="gs_gray">P Clézardin, S Sousa, M Croset, F Pantano, C Confavreux</div><div class="gs_gray">Academic Press<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:jgBuDB5drN8C" class="gsc_a_at">The therapeutic targeting of human receptor activator of nuclear factor kappa-B ligand (RANKL) directly impairs colonization of the bone marrow by RANK-expressing human breast&nbsp;…</a><div class="gs_gray">S Sousa, E Gineyts, S Geraci, L Bouazza, M Croset, P Clezardin, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 34, 175-175<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:lgwcVrK6X84C" class="gsc_a_at">Numerical Simulation of Metastatic Bone Strength</a><div class="gs_gray">H Follet, M Gardegaront, S Nicolle, JB Pialat, P Chaudier, M Brevet, ...</div><div class="gs_gray">3ème Journée Scientifique MSDAVENIR, -<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:QD3KBmkZPeQC" class="gsc_a_at">Targeting the calcium sensing receptor in breast cancer cells diminishes colonization and migratory response in a trabecular bone explant model, and reduces osteolytic lesions&nbsp;…</a><div class="gs_gray">S Das, A Gabrion, I Six, C Boudot, S Kamel, P Clezardin, M Brazier, ...</div><div class="gs_gray">Cancer Research 79 (13 Supplement), 2859-2859<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:4vMrXwiscB8C" class="gsc_a_at">Bone Metastases; Basic Aspects</a><div class="gs_gray">M Bernard, P Di Mauro, C Reynaud, C Diaz-Latoud, P Clézardin</div><div class="gs_gray">Academic Press<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:F1b5ZUV5XREC" class="gsc_a_at">Mechanical strength prediction of tumoral bones using numerical simulation</a><div class="gs_gray">B Delpuech, S Nicolle, JF Palierne, L Bouazza, JB Pialat, J Wegrzyn, ...</div><div class="gs_gray">Séminaire du Groupement de Recherche (GDR) CNRS MECABIO, 29 p<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">ERRa in primary breast tumours promotes tumour cell dissemination to bone by regulating RANK</a><div class="gs_gray">G Vargas, M Bouchet, C Kan, C Benetollo, M Croset, M Mazel, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 33, 72-72<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:LgRImbQfgY4C" class="gsc_a_at">RANK expression predicts long term outcome in early luminal breast cancer</a><div class="gs_gray">L Kassem, P Clézardin, I Treilleux</div><div class="gs_gray">Annals of Oncology 29, vi31<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:jL-93Qbq4QoC" class="gsc_a_at">Determination of tumor tissue mechanical properties, toward quantification of implication of tumor in whole bone resistance: a preliminary study</a><div class="gs_gray">B Delpuech, S Nicolle, C Confavreux, L Bouazza, S Geraci, P Clézardin, ...</div><div class="gs_gray">8th World Congress of Biomechanics<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:u-coK7KVo8oC" class="gsc_a_at">RANK-RANKL signaling inhibition delays early breast cancer bone metastasis formation</a><div class="gs_gray">S Sousa, E Gineyts, S Geraci, M Croset, P Clézardin</div><div class="gs_gray">Cancer Research 78 (13 Supplement), 29-29<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:kw52XkFRtyQC" class="gsc_a_at">Methods and pharmaceutical compositions for the treatment of bone metastases</a><div class="gs_gray">P Clezardin, B Eckel, DL Chantal, L Clement-demange</div><div class="gs_gray">US Patent App. 15/825,167<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:tYavs44e6CUC" class="gsc_a_at">Methods for Predicting and Treating Bone Metastases in Prostate Cancer Patients</a><div class="gs_gray">E Bonnelye, A Fradet, P Clezardin</div><div class="gs_gray">US Patent App. 14/436,639<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:5icHVeHT4IsC" class="gsc_a_at">Roundabout receptors: new actors in bone metastatic niche formation</a><div class="gs_gray">L Clement-Demange, PF Le, B Eckel, S Geraci, C Diaz-Latoud, ...</div><div class="gs_gray">Bone Abstracts 5<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Lysyl oxidase promotes survival and outgrowth of colon cancer cells in the bone marrow, enabling bone metastasis formation</a><div class="gs_gray">C Reynaud, L Ferreras, M Brevet, P Clezardin</div><div class="gs_gray">Bone Abstracts 5<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Bone and metabolic parameters are associated with overall survival in patients with bone metastases from adenocarcinoma lung cancer: the POUMOS study</a><div class="gs_gray">CB Confavreux, L Chambard, E Ollier, M Brevet, F Duboeuf, JC Rousseau, ...</div><div class="gs_gray">Bone Abstracts 5<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:qjMakFHDy7sC" class="gsc_a_at">Integrin α5 is an independent prognosis factor and a potential therapeutic target for breast cancer bone metastasis</a><div class="gs_gray">F Pantano, M Croset, K Driouch, E Bonnelye, N Bednarz-Knoll, SS Hong, ...</div><div class="gs_gray">Bone Abstracts 5<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:yB1At4FlUx8C" class="gsc_a_at">Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological&nbsp;…</a><div class="gs_gray">P Garnero, S Contie, N Rousselot, P Clezardin</div><div class="gs_gray">US Patent 9,115,190<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Evaluation of Eventual Risks of Unseeded Inertial Cavitation for Enhancing the Delivery of Chemotherapies</a><div class="gs_gray">M Lafond, JL Mestas, F Prieur, K Chettab, P Clézardin, C Lafon</div><div class="gs_gray">Journées RITS 2015, p70-71 Section imagerie et thérapie par ultrasons<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">THE HIF-1 TARGET LYSYL OXIDASE PROMOTES SURVIVAL AND OUTGROWTH OF COLON CANCER CELLS IN THE BONE MARROW ENABLING BONE METASTASIS FORMATION</a><div class="gs_gray">C Reynaud, L Ferreras, P Clezardin</div><div class="gs_gray">ANTICANCER RESEARCH 34 (10), 6134-6134<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:evX43VCCuoAC" class="gsc_a_at">Methods and pharmaceutical compositions for the treatment of bone metastases</a><div class="gs_gray">P Clezardin, B Eckel, DL Chantal, L Clement-demange</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Integrin Alpha5beta1 is a Potential Therapeutic Target to Treat Experimental Breast Cancer Bone Metastasis.</a><div class="gs_gray">F Pantano, M Croset, K Driouch, E Bonnelye, M Iuliani, M Fioramonti, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 29, S65-S65<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Roundabout receptors mediate breast cancer bone metastasis formation and progression.</a><div class="gs_gray">L Clement-Demange, B Eckel, V Gonin, D Goehrig, C Diaz-Latoud, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 29, S65-S66<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">ERRalpha, a pro-Bone metastatic factor: Implication in metastatic Niche and prostate Cancer Stem Cells phenotype.</a><div class="gs_gray">M Bouchet, A Fradet, C Delliaux, L Bouazza, F Pantano, X Leroy, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 29, S13-S13<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:7wO8s98CvbsC" class="gsc_a_at">Marion David1, Irma Machuca-Gayet2, Junichi Kikuta3, 4, Penelope Ottewell5, Fuka Mima3, 4, Raphael Leblanc1, Edith Bonnelye1, Johnny Ribeiro1, Ingunn Holen5, Rùben Lopez Vales6</a><div class="gs_gray">P Jurdic, J Chun, P Clézardin, M Ishii, O Peyruchaud</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:HIFyuExEbWQC" class="gsc_a_at">563 Hsp90 pharmacoproteomics: Harnessing pleiotropy for therapeutic synergy</a><div class="gs_gray">R Goldstein, G Chiosis, LC Cerchietti, AM Melnick</div><div class="gs_gray">European Journal of Cancer, 182<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">POUMOS: étude prospective de faisabilité du diagnostic moléculaire sur biopsie de métastase osseuse synchrone de cancer bronchopulmonaire</a><div class="gs_gray">N Girard, CB Confavreux, JB Pialat, M Devouassoux, P Clézardin, S Isaac, ...</div><div class="gs_gray">Revue des Maladies Respiratoires 31, A131<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">562 Lysophosphatidic acid-induced breast cancer metastasis depends on LPA1/ZEB1/miR-21-activation pathway</a><div class="gs_gray">D Sahay, R Leblanc, J Ribeiro, P Clezardin, O Peyruchaud</div><div class="gs_gray">European Journal of Cancer, 182<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis</a><div class="gs_gray">F Pantano, M Croset, K Driouch, D Santini, G Tonini, P Clezardin</div><div class="gs_gray">CANCER RESEARCH 73<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:hC7cP41nSMkC" class="gsc_a_at">Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis</a><div class="gs_gray">F Pantano, M Croset, K Driouch, D Santini, G Tonini, P Clézardin</div><div class="gs_gray">Cancer Research 73 (24 Supplement), P5-04-13-P5-04-13<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Bone, terapeutic target (RPC 2013)</a><div class="gs_gray">MH Vieillard, J Chiras, P Clezardin, JM Ferrero, J Barriere, P Beuzeboc</div><div class="gs_gray">ONCOLOGIE 15 (12), 673-687<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">Method for determining cancer prognosis</a><div class="gs_gray">E Bonnelye, A Fradet, P Clezardin</div><div class="gs_gray">US Patent App. 13/982,843<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:u9iWguZQMMsC" class="gsc_a_at">MUTATIONAL PROFILING OF SYNCHRONOUS BONE METASTASES FROM LUNG ADENOCARCINOMA: FEASIBILITY AND RESULTS IN A PROSPECTIVE COHORT OF 46 PATIENTS (POUMOS STUDY)</a><div class="gs_gray">M Brevet, CB Confavreux, JB Pialat, M Devouassoux-Shisheboran, ...</div><div class="gs_gray">JOURNAL OF THORACIC ONCOLOGY 8, S796-S796<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:HE397vMXCloC" class="gsc_a_at">Function of ERRa in Mediating Mixed Metastatic Bone Lesion from Prostate Cancer Cells: Implication of Endothelin 1 and Wnt/periostin pathway</a><div class="gs_gray">A Fradet, A Bellahcene, V Castronovo, PAR Clezardin, E Bonnelye</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 28<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:e_rmSamDkqQC" class="gsc_a_at">Bioluminescence Imaging of Prenylation Inhibition–Letter</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">Clinical Cancer Research 18 (21), 6077-6077<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:4DMP91E08xMC" class="gsc_a_at">Efficacy of bisphosphonate zoledronic acid is substantially improved by low intensity ultrasound in the treatment of breast cancer bone metastases in animals</a><div class="gs_gray">S Tardoski, D Melodelima, J Ngo, D Goehrig, P Clézardin</div><div class="gs_gray">Acoustics 2012<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:_kc_bZDykSQC" class="gsc_a_at">The role of the calcium sensing receptor in the migration of breast cancer cells</a><div class="gs_gray">U Thiem, C Boudot, I Lopez, L Hénaut, P Clézardin, S Kamel, ...</div><div class="gs_gray">Bone 6 (51), S28-S29<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:AHdEip9mkN0C" class="gsc_a_at">PATHOPHYSIOLOGY OF TUMORAL BONE DISEASE</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">OSTEOPOROSIS INTERNATIONAL 22, 6-7<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:rmuvC79q63oC" class="gsc_a_at">Potential control of the progress of bone metastasis through interaction between autotaxin and AlphaV-Beta3 integrin</a><div class="gs_gray">O Peyruchaud, D Marion, L Raphael, S Claire-Marie, R Johnny, ...</div><div class="gs_gray">BULLETIN DU CANCER 98, S8-S8<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">Role of axon guidance receptor Robo-1 in training and development of bone metastases of breast cancer</a><div class="gs_gray">C Diaz-Latoud, V Gonin, B Eckel, R Bachelier, B Deux, E Bonnelye, ...</div><div class="gs_gray">BULLETIN DU CANCER 98, S27-S28<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">The HIF-1-inducible Lysyl Oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell</a><div class="gs_gray">C Reynaud, F Pez, F Dayan, P Clezardin, P Sommer, J Pouyssegur</div><div class="gs_gray">BULLETIN DU CANCER 98, S9-S10<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">Clinical and basic research papers-February 2011</a><div class="gs_gray">S Ferrari, E Seeman, P Clézardin, D Karasik, DG Little, T Matsumoto</div><div class="gs_gray">IBMS BoneKEy 8, 65<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:PaBasH6fAo0C" class="gsc_a_at">Zoledronic acid induces IPP accumulation and release from human cancer cells, which activates Vg9Vd2 T cell-differentiation and migration in vitro and mediates Vg9Vd2 T cell&nbsp;…</a><div class="gs_gray">H Monkkonen, V Stresing, E Bonnelye, J Green, J Monkkonen, ...</div><div class="gs_gray">BONE-NEW YORK- 48 (1), S46-S46<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:LO7wyVUgiFcC" class="gsc_a_at">Erratum to “Periostin as a circulating marker for breast cancer bone metastases”[Bone 47S2 (2010) S328–S329]</a><div class="gs_gray">S Contié, N Voorzanger-Rousselot, J Litvin, P Clézardin, P Garnero</div><div class="gs_gray">Bone 3 (48), 672<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Physiopathologie et interêt des inhibiteurs de RANKL dans le traiterement des metastases osseusas du cancer de la prostate</a><div class="gs_gray">P CLEZARDIN</div><div class="gs_gray">JOG, le journal d'oncogériatrie 2 (6), 233-238<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">5007 ORAL The MicroRNAs-30 Family Interferes With the Formation of Breast Cancer Bone Metastases by Targeting Osteomimetic Genes</a><div class="gs_gray">M Croset, R Bachelier, N Allioli, SS Hong, R Aqami, P Clezardin</div><div class="gs_gray">European Journal of Cancer, S332<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Zoledronic acid induces IPP accumulation and release from human cancer cells, which activates Vγ9Vδ2 T cell-differentiation and migration in vitro and mediates Vγ9Vδ2 T cell&nbsp;…</a><div class="gs_gray">I Benzaid, H Monkkonen, V Stresing, E Bonnelye, J Green, J Monkkonen, ...</div><div class="gs_gray">Bone 1 (48), S46<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Twist 1 expression in an osteotropic breast cancer cell line promotes bone metastasis formation in mouse</a><div class="gs_gray">M Croset, D Goëhrig, E Bonnelye, S Ansieau, A Puisieux, P Clézardin</div><div class="gs_gray">Bone 1 (48), S47-S48<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Clinical and basic research papers-October 2010</a><div class="gs_gray">S Ferrari, E Seeman, D Karasik, DG Little, T Matsumoto</div><div class="gs_gray">IBMS BoneKEy 7, 333<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:foquWX3nUaYC" class="gsc_a_at">Clinical and basic research papers-September 2010</a><div class="gs_gray">S Ferrari, E Seeman, D Karasik, DG Little, T Matsumoto</div><div class="gs_gray">IBMS BoneKEy 7, 291<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:blknAaTinKkC" class="gsc_a_at">Propriétés antitumorales du bisphosphonate zolédronate et implications thérapeutiques potentielles en clinique</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Bulletin du cancer 97 (8), 937-949<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">The combined targeting of VEGF-A and VEGF receptors inhibits breast cancer bone metastases in mice</a><div class="gs_gray">R Bachelier, V Gonin, D Goehrig, B Deux, G Pluijm, P Clezardin</div><div class="gs_gray">BONE 47, S322S323<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:URolC5Kub84C" class="gsc_a_at">Periostin as a circulating marker for breast cancer bone metastases</a><div class="gs_gray">CWG Lowik, S Contie, N Voorzanger-Rousselot, J Litvin, P Clezardin, ...</div><div class="gs_gray">BONE 47, S328-S329<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:maZDTaKrznsC" class="gsc_a_at">Autotaxin/Enpp2 controls of bone metastasis formation through osteoclast function</a><div class="gs_gray">M David, E Wannecq, S Jansen, B Deux, J Ribeiro, CM Serre, S Grès, ...</div><div class="gs_gray">Cancer Research 70 (8 Supplement), 2368-2368<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">Frequent Intermittent Low-dose Therapy Accentuates the Antitumour Activity of the Bisphosphonate Risedronate In Vivo</a><div class="gs_gray">V Stresing, B Deux, I Benzaid, P Mathevet, H Ebetino, P Clézardin</div><div class="gs_gray">Bone, S43<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:LI9QrySNdTsC" class="gsc_a_at">674 EXPRESSION OF INTEGRIN ALPHA 2 AND ALPHA 6 AND C-MET IN PRIMARY PROSTATE CARCONIMA: IMPACT ON BONE METASTASIS FREE SURVIVAL</a><div class="gs_gray">E Ricci, E Bourrelly, LF Mege, X Martin, P Clezardin, M Colombel</div><div class="gs_gray">European Urology Supplements 2 (9), 221<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:35r97b3x0nAC" class="gsc_a_at">531 Synergy between HIF1a and LOX is critical for tumour progression</a><div class="gs_gray">F Pez, F Dayan, J Durivault, B Kaniewski, G Aimond, B Deux, P Clezardin, ...</div><div class="gs_gray">ejc supplements 5 (8), 135-136<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Committees and contact information</a><div class="gs_gray">L Calvi, P Clézardin, C Cooper, R Eastell, C Farquharson, S Ferrari, ...</div><div class="gs_gray">Bone 47, S1-S4<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Zoledronic acid induces IPP release from cancer cells which causes Vgamma9Vdelta2 T cell expansion in PBMCs</a><div class="gs_gray">S Arkko, J Mönkkönen, S Auriola, IR Dronda, I Benzaid, V Stresing, ...</div><div class="gs_gray">Bone, S40-S41<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:qUcmZB5y_30C" class="gsc_a_at">Clinical and basic research papers-July 2009</a><div class="gs_gray">S Ferrari, E Seeman, H Deng, DG Little, T Matsumoto</div><div class="gs_gray">IBMS BoneKEy 6, 232<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:9pM33mqn1YgC" class="gsc_a_at">Development of a new ELISA for serum periostin: Growth-related changes and effects of bisphosphonate in mice</a><div class="gs_gray">S Contié, N Voorzanger-Rousselot, J Litvin, N Bonnet, S Ferrari, ...</div><div class="gs_gray">Bone, S270<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Effect of lysophosphatidic acid (LPA) on osteoclastogenesis</a><div class="gs_gray">CM Serre, J Ribeiro, E Bonnelye, P Clézardin, O Peyruchaud</div><div class="gs_gray">Bone, S135<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Bioactive Lipids Lysophosphatidic Acid and Sphingosine 1-Phosphate Mediate Breast Cancer Cell Biological Functions Through Distinct Mechanisms (vol 18, pg 173, 2009)</a><div class="gs_gray">A Boucharaba, B Guillet, F Menaa, M Hneino, AJ van Wijnen, P Clezardin, ...</div><div class="gs_gray">Oncology Research 18 (ARTICLE), 357-357<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:abG-DnoFyZgC" class="gsc_a_at">Committees and contact information</a><div class="gs_gray">R Eastell, R Baron, S Boonen, H Dobnig, S Ferrari, P Fratzl, P Garnero, ...</div><div class="gs_gray">Bone 44, S187-S188<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Platelets Contribute to Circulating Levels of Dickkopf-1 (Dkk-1): Clinical Implications in Multiple Myeloma.</a><div class="gs_gray">N Voorzanger-Rousselot, D Goehrig, P Clezardin, T Facon, P Garnero</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 23, S297-S297<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:0izLItjtcgwC" class="gsc_a_at">Lysophospholipids LPA and S1P cooperate to mediate the growth and osteolytic bone metastasis formation of breast cancer</a><div class="gs_gray">A Boucharaba, B Guillet, F Menaa, M Heino, A VanWijnen, P Clezardin, ...</div><div class="gs_gray">Cancer Research 68 (9 Supplement), 3685-3685<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Autotaxin controls breast cancer growth and metastasis in preclinical mouse models</a><div class="gs_gray">M David, B Deux, CM Serre, BV Nathalie, C Christophe, ...</div><div class="gs_gray">Cancer Research 68 (9 Supplement), 344-344<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Autotaxin controls the metastatic progression of breast cancer cells</a><div class="gs_gray">M David, B Deux, CM Serre, N Bendriss-Vermare, C Caux, ...</div><div class="gs_gray">BULLETIN DU CANCER 95, S91-S92<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:IRz6iEL74y4C" class="gsc_a_at">P57. Manipulating the bone mineral affinity of bisphosphonates to directly target cancer cells in the bone marrow</a><div class="gs_gray">F Daubiné, P Fournier, H Ebetino, P Clezardin</div><div class="gs_gray">Cancer Treatment Reviews 34, 42<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:vDijr-p_gm4C" class="gsc_a_at">P56. Targeting VEGF and its receptors in the treatment of breast cancer bone metastases</a><div class="gs_gray">R Bachelier, V Gonin, D Goehrig, B Deux, P Clézardin</div><div class="gs_gray">Cancer Treatment Reviews 34, 41<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Cathepsin K inhibitors for treating cancer-induced bone disease</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">CLINICAL &amp; EXPERIMENTAL METASTASIS 25, 15-15<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">New physiopathological pathways of bone metastases</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">CALCIFIED TISSUE INTERNATIONAL 82, S24-S24<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">P20. Autotaxin promotes metastasis dissemination of breast cancer cells</a><div class="gs_gray">M David, E Wannecq, S Grès, B Deux, CM Serre, N Bendriss-Vermare, ...</div><div class="gs_gray">Cancer Treatment Reviews 34, 20-21<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:vRqMK49ujn8C" class="gsc_a_at">P49. Zoledronic acid-induced IPP accumulation in cancer cells strongly correlates with# 947# 948 T-cell mediated cancer cell death</a><div class="gs_gray">I Benzaid, V Stresing, J Green, J Monkkonen, JL Touraine, P Clezardin</div><div class="gs_gray">Cancer Treatment Reviews 34 (1), 37<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:IWHjjKOFINEC" class="gsc_a_at">P49. Zoledronic acid-induced IPP accumulation in cancer cells strongly correlates with γδ T-cell mediated cancer cell death</a><div class="gs_gray">H Monkkonen, I Benzaid, V Stresing, J Green, J Monkkonen, JL Touraine, ...</div><div class="gs_gray">Cancer Treatment Reviews 34, 37<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:8d8msizDQcsC" class="gsc_a_at">Differential effects of doxorubicin and zoledronic acid on intra-osseous vs extra-osseous breast tumour growth in vivo</a><div class="gs_gray">P Ottewell, B Deux, H Monkkonen, S Cross, R Coleman, P Clezardin, ...</div><div class="gs_gray">Breast Cancer Research and Treatment 106<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">Differential effect of doxorubicin and zoledronic acid on intra-osseous vs extra osseous breast tumour growth in vivo</a><div class="gs_gray">PD Ottewell, B Deux, H Monkkonen, RE Coleman, P Clezardin, I Holen</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 22 (7), 1111-1111<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Role of lysophosphatidic acid (LPA) and LPA1 receptor in the treatment of bone metastases in breast cancer</a><div class="gs_gray">A Boucharaba, F Menaa, P Clezardin, O Peyruchaud</div><div class="gs_gray">BULLETIN DU CANCER 94 (6), 560-561<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">1302 POSTER Updated International Society of Geriatric Oncology (SIOG) recommendations for the use of bisphosphonates in elderly cancer patients with bone metastases</a><div class="gs_gray">JJ Body, R Coleman, P Clezardin, C Ripamonti, R Rizzoli, M Aapro</div><div class="gs_gray">EJC Supplements 4 (5), 174<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Transmigration, a new property of mature osteoclasts.</a><div class="gs_gray">F Saltel, A Chabadel, Y Zhao, M Lafage-Proust, P Clezardin, P Jurdic, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 21, S161-S161<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:XvxMoLDsR5gC" class="gsc_a_at">The type 1 lysophosphatidic acid receptor (LPA1): identification of a new therapeutic target for patients with bone metastases</a><div class="gs_gray">O Peyruchaud, A Boucharaba, CM Serre, P Clezardin</div><div class="gs_gray">Cancer Research 66 (8 Supplement), 63-63<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">Continuous or repeated intermittent low-dose therapy with zoledronic acid induces a sustained inhibition of tumor cell trafficking to bone in vivo</a><div class="gs_gray">J Guglielmi, F Daubiné, J Gasser, J Green, P Clézardin</div><div class="gs_gray">Bone 3 (38), 44-45<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:p__nRnzSRKYC" class="gsc_a_at">The type 1 lysophosphatidic acid receptor is a pivotal factor for early and late events for bone metastasis formation in breast cancer</a><div class="gs_gray">A Boucharaba, P Clezardin, O Peyruchaud</div><div class="gs_gray">CANCER TREATMENT REVIEWS 32, S30-S30<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:t6usbXjVLHcC" class="gsc_a_at">A cathepsin k inhibitor (alone or in combination with zoledronic acid) inhibits the progression of breast cancer bone metastases</a><div class="gs_gray">C Le Gall, J Guglielmi, J Gasser, J Zimmermann, P Clézardin</div><div class="gs_gray">Bone 3 (38), 55-56<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:1qzjygNMrQYC" class="gsc_a_at">Effects of thrombospondin-1 overexpression and VEGF silencing on bone metastasis formation</a><div class="gs_gray">R Bachelier, V Gonin, D Goehrig, C Confavreux, P Clezardin</div><div class="gs_gray">CANCER TREATMENT REVIEWS 32, S41-S41<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Serum levels of Dickkopf-1 (Dkk-1) are increased in women with breast cancer and bone metastases</a><div class="gs_gray">N Voorzanger-Rousselot, D Goehrig, P Clezardin, P Garnero</div><div class="gs_gray">CANCER TREATMENT REVIEWS 32, S38-S38<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Integrin alpha V beta 3 confers tumor cells a higher sensitivity to the pro-apoptotic effect of the aminobisphosphonate zoledronate in vitro</a><div class="gs_gray">F Daubine, P Fournier, P Boucher, P Clezardin</div><div class="gs_gray">CANCER TREATMENT REVIEWS 32, S45-S46<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Antitumour Effects of Bisphosphonates</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">Textbook of Bone Metastases, 345<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Antitumour Effects of Bisphosphonates</a><div class="gs_gray">RE Coleman, P Clézardin</div><div class="gs_gray">Textbook of Bone Metastases, 345-350<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:a9-T7VOCCH8C" class="gsc_a_at">Acide lysophosphatidique: un nouveau lien entre plaquettes sanguines et métastases osseuses</a><div class="gs_gray">O Peyruchaud, A Boucharaba, JS Saulnier-Blache, P Clézardin</div><div class="gs_gray">M/S: médecine sciences 21 (4), 353-355<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Use of bisphosphonate analogs of risedronate to elucidate antiangiogenic mechanisms of bisphosphonates in vivo</a><div class="gs_gray">P Fournier, FH Ebetino, A Bellahcene, V Castronovo, P Clezardin</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 20, P24-P24<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Genome profiling aiming at identifying" bone metastasis signatures"</a><div class="gs_gray">A Jackson, P Pujuguet, P Clement-Lacroix, R Baron, P Clezardin, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 20, P36-P36<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Transcriptome analysis reveals an osteomimetic phenotype for human breast cancer cells that selectively target the skeleton</a><div class="gs_gray">A Bellahcene, R Bachelier, C Detry, P Clezardin, V Castronovo</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 20, P32-P32<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">LPA: A new local factor acting on breast cancer bone metastasis</a><div class="gs_gray">A Boucharaba, C Serre, JS Blache, J Bordet, P Clezardin, O Peyruchaud</div><div class="gs_gray">CANCER TREATMENT REVIEWS 31, S27-S27<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:anf4URPfarAC" class="gsc_a_at">A nonpeptide integrin avb3 antagonist inhibits bone metastasis formation</a><div class="gs_gray">J Guglielmi, I Pecheur, P Pujuguet, D Minet, R Baron, P Clement-Lacroix, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 19, S66-S66<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Lysophosphatidic acid: A new link between breast cancer and bone metastasis.</a><div class="gs_gray">A Boucharaba, C Serre, JS Blache, J Bordet, J Guglielmi, P Clezardin, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 19, S25-S25<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">The bisphosphonate risedronate inhibits angiogenesis and tumor growth in vivo</a><div class="gs_gray">P Fournier, CM Serre, M Colombel, FH Ebetino, P Clezardin</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 19 (9), 1599-1599<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">NE-10790, a phosphonocarboxylate analogue of the bisphosphonate risedronate, exhibits direct antitumor activity in vivo</a><div class="gs_gray">MW Lundy, FH Ebetino, P Clezardin</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 19 (6), 1033-1033<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Rôle de l'angiogenèse tumorale dans le processus métastatique osseux?: Ostéoporose</a><div class="gs_gray">O PEYRUCHAUD, CM SERRE, R NICAMHLAOIBH, C SVEIGAARD, ...</div><div class="gs_gray">Revue médicale de la Suisse romande 124 (2), 83-84<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">The bisphosphonate risedronate inhibits angiogenesis and tumor growth in vivo.</a><div class="gs_gray">P Fournier, S Boissier, C Serre, M Colombel, FH Ebetino, PAR Clezardin</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 18, S113-S113<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:_B80troHkn4C" class="gsc_a_at">BIPHOSPHONATES AND BONE METASTASES OF SOLID TUMORS: THERAPEUTIC SIGNIFICANCE BEYOND OSTEOLYTIC ACTIVITY</a><div class="gs_gray">P CLÉZARDIN</div><div class="gs_gray">PROGRES EN UROLOGIE 13 (2 SUPPL 1), 28-35<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:LPZeul_q3PIC" class="gsc_a_at">Androgens repress the expression of thrombospondin-1, an inhibitor of angiogenesis, in the rat prostate and in hormone-responsive human prostate cancer</a><div class="gs_gray">M Colombel, P Fournier, R Bouvier, F Cabon, P Clezardin</div><div class="gs_gray">European Urology Supplements 1 (2), 82<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Activité anti-tumorale des bisphosphonates: mythe ou réalité?</a><div class="gs_gray">P Clézardin</div><div class="gs_gray">Revue du rhumatisme 69 (10-11), 997-1001<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Integrin alpha v beta 3 plays an essential role in the homing of tumor cells in bone.</a><div class="gs_gray">I Pecheur, O Peyruchaud, P Fournier, CM Sarre, F Bourre, PD Delmas, ...</div><div class="gs_gray">BONE 30 (3), 43S-43S<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:XoXfffV-tXoC" class="gsc_a_at">Experimental Therapeutics-Bisphosphonates Inhibit Angiogenesis in Vitro and Testosterone-stimulated Vascular Regrowth in the Ventral Prostate in Castrated Rats.</a><div class="gs_gray">P Fournier, S Boissier, S Filieur, J Guglielmi, F Cabon, M Colombel, ...</div><div class="gs_gray">Cancer Research 62 (22), 6538-6544<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">The bisphosphonate zoledronic acid inhibits angiogenesis in vitro and testosterone-stimulated vascular regrowth in the rat ventral prostate</a><div class="gs_gray">M Colombel, P Fournier, S Boissier, X Martin, P Clezardin</div><div class="gs_gray">European Urology Supplements 1 (1), 52<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Mécanismes de formation des métastases ostéolytiques et ostéocondensantes des tumeurs solides</a><div class="gs_gray">P CLEZARDIN</div><div class="gs_gray">La Lettre du rhumatologue, 11-15<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Effets des bisphosphonates sur differentes etapes de la cascade metastatique conduisant a la formation des metastases osseuses</a><div class="gs_gray">P Clezardin</div><div class="gs_gray">MEDECINE ET HYGIENE, S13-S14<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Regular Articles-Experimental Therapeutics-Bisphosphonates Inhibit Breast and Prostate Carcinoma Cell Invasion, an Early Event in the Formation of Bone Metastases</a><div class="gs_gray">S Boissier, M Ferreras, O Peyruchaud, S Magnetto, FH Ebetino, ...</div><div class="gs_gray">Cancer Research 60 (11), 2949-2954<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Ectopic Expression of Integrin alpha v beta 3 Confers Tumor Cells a High Propensity to Metastasize to Bone</a><div class="gs_gray">I Pecheur, M David, S Schaffer-Reckinger, PD Delmas, N Kieffer, ...</div><div class="gs_gray">JOURNAL OF BONE AND MINERAL RESEARCH 15 (1), 1155-1161<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Experimental Cancer-Additive antitumor activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to&nbsp;…</a><div class="gs_gray">S Magneito, S Boissier, PD Delmas, P Clezardin</div><div class="gs_gray">International Journal of Cancer 83 (2), 263-269<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:TFP_iSt0sucC" class="gsc_a_at">La modulation de l'angiogénèse prostatique</a><div class="gs_gray">I Bah, MP David, PG Konan, P Clezardin, M Colombel</div><div class="gs_gray">Oncologie (Paris) 1 (7), 428-432<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Thrombospondines, angiogenèse tumorale et cancer du sein</a><div class="gs_gray">P CLEZARDIN, G BRUNO-BOSSIO, A FONTANA, CM SERRE, ...</div><div class="gs_gray">Pathologie et biologie 47 (4), 368-374<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Identification of specific sequences within thrombospondin-1 involved in the formation of irreversible platelet macroaggregates</a><div class="gs_gray">C Voland, B Kehrel, H Grahe, J Amiral, J Lawler, P Clezardin</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, P1385-P1385<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">BISPHOSPHONATES INHIBIT TUMOR CELL ATTACHMENT TO UNMINERALIZED AND MINERALIZED BONE EXTRACELLULAR MATRICES</a><div class="gs_gray">S Boissier, S Lozano, B Cuzin, P Delmas, P Clezardin</div><div class="gs_gray">Journal of Bone and Mineral Research 11<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">DECORIN INHIBITS CELL ADHESION BY BINDING TO A SPECIFIC CELL ADHESIVE SITE OF THROMBOSPONDIN</a><div class="gs_gray">B Merle, H Choi, J Amiral, L Rosenberg, J Lawler, P Delmas, P Clezardin</div><div class="gs_gray">Journal of Bone and Mineral Research 11<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Se3iqnhoufwC" class="gsc_a_at">MOLECULAR MECHANISMS OF ATTACHMENT OF CD36-TRANSFECTED CELLS TO THROMBOSPONDIN-1</a><div class="gs_gray">P CLEZARDIN, S LOZANO, J LAWLER, R SILVERSTEIN, J LECERF, ...</div><div class="gs_gray">MOLECULAR BIOLOGY OF THE CELL 6, 267-267<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">MECHANISMS OF PLATELET-OSTEOSARCOMA CELL-INTERACTIONS</a><div class="gs_gray">P CLEZARDIN, J DROUIN, C KAPLAN, M HANSS, B KEHREL, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 69 (6), 573-573<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:uLbwQdceFCQC" class="gsc_a_at">ORIGIN AND ROLE OF THROMBOSPONDIN IN THE EARLY DEVELOPMENT OF THE HUMAN MAMMARY-GLAND</a><div class="gs_gray">L FRAPPART, P CLEZARDIN, R DANTE, CM SERRE, M CLERGET, ...</div><div class="gs_gray">JOURNAL OF CELLULAR BIOCHEMISTRY, 160-160<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">Role of osteoclasts in the physiopathological mechanisms of malignant osteolysis</a><div class="gs_gray">P Clézardin, PD Delmas</div><div class="gs_gray">Bulletin du cancer 80 (10 Suppl), 11-15<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">Distribution of thrombospondin and its CD36 receptor in human mammary anlages and adult breast carcinoma</a><div class="gs_gray">S Claire‐Marie, C Magali, C Philippe, F Lucien, B Georges</div><div class="gs_gray">Biology of the Cell 79 (1), 86-86<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">PSEUDO-GRAY PLATELET SYNDROME-MULTIPLE PLATELET ABNORMALITIES AND NORMAL HEMOSTASIS</a><div class="gs_gray">J DROUIN, W MCLEISH, M SUTHERLAND, P CLEZARDIN</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 65 (6), 1105-1105<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:z_wVstp3MssC" class="gsc_a_at">THROMBOSPONDIN AND CELL-ADHESION</a><div class="gs_gray">P CLEZARDIN, H JOUISHOMME, P CHAVASSIEUX, PJ MARIE</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 62 (1), 592-592<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">OSTEONECTIN DEFICIENCY IN PLATELETS ISOLATED FROM A PATIENT WITH THE GRAY PLATELET SYNDROME</a><div class="gs_gray">P CLEZARDIN, L MALAVAL, PD DELMAS, C KAPLAN</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 62 (1), 420-420<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:8xutWZnSdmoC" class="gsc_a_at">RAPID PURIFICATION AND PARTIAL CHARACTERIZATION OF HUMAN-PLATELET GLYCOPROTEIN IIIB</a><div class="gs_gray">J MCGREGOR, B CATIMEL, S PARAMENTIER, P CLEZARDIN, ...</div><div class="gs_gray">CLINICAL RESEARCH 36 (3), A567-A567<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:bKqednn6t2AC" class="gsc_a_at">STRUCTURAL AND FUNCTIONAL COMPARISON OF THROMBOSPONDIN FROM PLATELETS, ENDOTHELIAL CELLS AND FIBROBLASTS</a><div class="gs_gray">P Clezardin, JL McGregor</div><div class="gs_gray">Thrombosis and Haemostasis 58 (05), 1020<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:Ehil0879vHcC" class="gsc_a_at">CHARACTERIZATION OF MONOCLONAL-ANTIBODIES WHICH AFFECT HUMAN-PLATELET THROMBOSPONDIN HEMAGGLUTINATION ACTIVITY</a><div class="gs_gray">P CLEZARDIN, JL MCGREGOR, M LYON, H BOUKERCHE, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 54 (1), 249-249<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:a3BOlSfXSfwC" class="gsc_a_at">Characterization of a Monoclonal Antibody Directed Against a Platelet Alpha-Granule Glycoprotein</a><div class="gs_gray">H BOUKERCHE, JL McGREGOR, L McGREGOR, P CLEZARDIN, ...</div><div class="gs_gray">Protides of the Biological Fluids 32, 821-824<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">STUDY ON THE RELEASE OF THROMBOSPONDINE DURING PLATELET CONSERVATION-DOSAGE BY MEANS OF THE ELISA METHOD, WITH A MONOCLONAL-ANTIBODY</a><div class="gs_gray">F ROBERT, JL MCGREGOR, P CLEZARDIN, A SAYEGH, ...</div><div class="gs_gray">NOUVELLE REVUE FRANCAISE D HEMATOLOGIE 27 (2), 117-117<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:cWzG1nlazyYC" class="gsc_a_at">MEMBRANEOUS PROTEINS AND GLYCOPROTEINS OF ENDOTHELIAL-CELLS FROM UMBILICAL CORDS</a><div class="gs_gray">JL MCGREGOR, B SICARD, P CLEZARDIN, E JAMES, KJ CLEMETSON, ...</div><div class="gs_gray">NOUVELLE REVUE FRANCAISE D HEMATOLOGIE 26 (6), 417-417<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:nZcligLrVowC" class="gsc_a_at">MEMBRANE-PROTEINS AND GLYCOPROTEINS OF ENDOTHELIAL-CELLS ISOLATED FROM HUMAN UMBILICAL CORDS</a><div class="gs_gray">JL MCGREGOR, B SICARD, E JAMES, P CLEZARDIN, M DECHAVANNE, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 50 (1), 396-396<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">PROTEINS AND GLYCOPROTEINS OF NEONATAL PLATELETS</a><div class="gs_gray">M BENDOUMA, JL MCGREGOR, P CLEZARDIN, M DECHAVANNE, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 50 (1), 213-213<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">PLATELET MEMBRANE GLYCOPROTEIN ABNORMALITIES IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS, ACUTE-LEUKEMIA AND SECONDARY THROMBOCYTOSIS</a><div class="gs_gray">P CLEZARDIN, JL MCGREGOR, M DECHAVANNE, KJ CLEMETSON</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 50 (1), 218-218<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:yFnVuubrUp4C" class="gsc_a_at">EFFECT OF THROMBOSPONDIN ON PLATELET ADP-INDUCED AGGREGATION AND I-125-FIBRINOGEN BINDING</a><div class="gs_gray">P CLEZARDIN, L MCGREGOR, JL MCGREGOR, KJ CLEMETSON, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 4, 5-5<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">TRYPTIC PEPTIDE MAPS OF THE MAJOR HUMAN-BLOOD PLATELET MEMBRANE-GLYCOPROTEINS, IIA, IIA, IIB, IIIA, IIIB AND IIIC</a><div class="gs_gray">JL MCGREGOR, KJ CLEMETSON, E JAMES, P CLEZARDIN, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 46 (1), 22-22<span class="gs_oph">, 1981</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1981</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Further Characterization Of Platelet Membrane Glycoproteins</a><div class="gs_gray">P Clezardin, JL McGregor, KJ Clemetson, M Dechavanne, EF Lüscher</div><div class="gs_gray">Thrombosis and Haemostasis 46 (05), 0330<span class="gs_oph">, 1981</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1981</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Tryptic Peptide Maps Of The Major Human Blood Platelet Membrane Glycoproteins, Ia, IIa, IIb, IIIa, IIIb and IIIc</a><div class="gs_gray">JL McGregor, KJ Clemetson, E James, P Clezardin, M Dechavanne, ...</div><div class="gs_gray">Thrombosis and Haemostasis 46 (05), 0058<span class="gs_oph">, 1981</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1981</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">Référence: Prog Urol, 2003, 1301, 28-35 PLAN:-Mécanismes d'action des bisphosphonates sur les cellules tumorales in vitro.-Effets des bisphosphonates dans la formation des&nbsp;…</a><div class="gs_gray">P CLÉZARDIN</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:ALROH1vI_8AC" class="gsc_a_at">La revue francophone de formation en oncologie</a><div class="gs_gray">MH VIEILLARD, J CHIRAS, P CLÉZARDIN, JM FERRERO, J BARRIÈRE, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">In Vivo Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Trigger Vg9Vd2 T-cell Antitumor Cytotoxicity through ICAM-1 Engagement</a><div class="gs_gray">I Benzaïd, H Mönkkönen, E Bonnelye, J Mönkkönen, P Clézardin</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:6yz0xqPARnAC" class="gsc_a_at">Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer</a><div class="gs_gray">JS Saulnier-Blache, JC Bordet, J Guglielmi, P Clézardin, O Peyruchaud</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Crabb, JW-and Heilmeyer, Jr., LMG Micropreparative protein purification by re-versed-phase high-performance liquid chro-matography 129</a><div class="gs_gray">R Bischoff, H Briickner, DH Calam, M Carlquist, P Clezardin, JL McGregor, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:eflP2zaiRacC" class="gsc_a_at">Hematopoietic Stem Cell Transplantation 2008 Education Supplement</a><div class="gs_gray">MRM van den Brink, FR Appelbaum, KR Cooke, SM Davies, J DiPersio, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:P5F9QuxV20EC" class="gsc_a_at">PLAN:-Mécanismes d'action des bisphosphonates sur les cellules tumorales in vitro.-Effets des bisphosphonates dans la formation des tumeurs et des métastases in vivo.-Activité&nbsp;…</a><div class="gs_gray">P CLÉZARDIN</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ZL2owqcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ZL2owqcAAAAJ:70eg2SAEIzsC" class="gsc_a_at">Role of Platelet Membrane Glycoproteins Ib/IX and llb/llla, and of Platelet s-Granule Proteins in Platelet Aggregation Induced by Human Osteosarcoma Cells</a><div class="gs_gray">P Clezardin, J Drouin, MC Morel-Kopp, M Hanss, B Kehrel, CM Serre</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–370</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>